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The generation of complex behaviors often requires the coordinated 
activity of diverse sets of neural circuits in the brain. Activation of neuronal 
circuits drives behavior. Inappropriate signaling can contribute to cognitive 
disorders such as epilepsy, Parkinson’s, and addiction (Nordberg et al., 1992; 
Quik and McIntosh, 2006; Steinlein et al., 2012). The molecular mechanisms by 
which the activity of neural circuits is coordinated remain unclear. What are the 
molecules that regulate the timing of neural circuit activation and how is signaling 
between various neural circuits achieved? While much work has attempted to 
address these points, answers to these questions have been difficult to ascertain, 
in part owing to the diversity of molecules involved and the complex connectivity 
patterns of neural circuits in the mammalian brain. 
My thesis work addresses these questions in the context of the nervous 
system of an invertebrate model organism, the nematode Caenorhabditis 
elegans. The locomotory circuit contains two subsets of motor neurons, 
excitatory and inhibitory, and the body wall muscle. Dyadic synapses from 
excitatory neurons coordinate the simultaneous activation of inhibitory neurons 
and body wall muscle. Here I identify a distinct class of ionotropic acetylcholine 
receptors (ACR-12R) that are expressed in GABA neurons and contain the 
subunit ACR-12. ACR-12R localize to synapses of GABA neurons and facilitate 
consistent body bend amplitude across consecutive body bends. ACR-12Rs 
regulate GABA neuron activity under conditions of elevated ACh release. This is 
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in contrast to the diffuse and modulatory role of ACR-12 containing receptors 
expressed in cholinergic motor neurons (ACR-2R) (Barbagallo et al., 2010; 
Jospin et al., 2009). Additionally, I show transgenic animals expressing ACR-12 
with a mutation in the second transmembrane domain [ACR-12(V/S)] results in 
spontaneous contractions. Unexpectedly, I found expression of ACR-12(V/S) 
results in the preferential toxicity of GABA neurons. Interestingly loss of 
presynaptic GABA neurons did not have any obvious effects on inhibitory NMJ 
receptor localization. Together, my thesis work demonstrates the diverse roles of 
nicotinic acetylcholine receptors (nAChRs) in the regulation of neuronal activity 
that underlies nematode movement. The findings presented here are broadly 
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 The nervous system is a complex and highly interconnected 
network of specialized cells called neurons. Groups of connecting neurons form 
circuits that modify behavior based on activity. These neurons are interconnected 
by two mechanisms: the electrical synapse, or gap junction, and a unique 
chemical junction called a synapse. Electrical coupling or gap junctions are a 
direct low resistance mechanism for transmitting electrical activity from one 
neuron to a neighboring neuron or other cell type. The gap junction is comprised 
of a hydrophilic intercellular channel, with one subunit of the channel contributed 
from each of the connecting cells (Flores et al., 2012; Pereda et al., 2012). In 
contrast, synapses utilize chemical transmission. An electrical signal from the 
presynapse triggers the release of a neurotransmitter into the synaptic cleft. After 
diffusing across the cleft, the neurotransmitter binds to receptors located on the 
postsynaptic neuron. Fast synaptic transmission is mediated by ionotropic 
receptors, also known as ligand-gated ion channels (LGICs). Binding of the 
chemical neurotransmitter triggers a conformational change in the receptor, 
opening a pore through the membrane that allows the flow of ions into or out of 
the cell, and converting the chemical signal into an electrical response (Holtmaat 
and Svoboda, 2009). Chemical signaling through a synapse translates into one 
of two simple outcomes: (1) the activation of the postsynaptic neuron and 
continued neuronal transmission or (2) the inhibition of the postsynaptic neuron 
that reduces downstream signaling. Signaling at synapses occurs on a time scale 
of milliseconds, allowing for rapid activation or inhibition of sequential neurons 
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within a circuit to appropriately drive circuit activity and ultimately determine 
behavior. 
The generation of complex behaviors often requires the coordinated 
activity of diverse sets of neural circuits in the brain. The molecular mechanisms 
by which the activity of neural circuits is coordinated remain unclear. What are 
the molecules that regulate the timing of neural circuit activation and how is 
signaling between various neural circuits achieved? These are important 
questions, as disruption of coordinated circuit activity can have severe 
consequences (e.g., epilepsy). While scientific research has attempted to 
address these points, answers to these questions have been difficult to ascertain, 
in part owing to the diversity of molecules involved and the complex connectivity 
patterns of neural circuits in the mammalian brain. My thesis work addresses 
these questions in the context of the nervous system of an invertebrate model 
organism, the nematode Caenorhabditis elegans. The genetic tools available and 
well-established connectivity of this organism make it ideal for this type of study. 
As the major neurotransmitter in C. elegans is acetylcholine, a detailed 
description of cholinergic signaling and the molecules involved follows. 
Ligand-gated ion channels and synaptic transmission 
The ligand-gated gated ion channel (LGIC) super family includes 
receptors for the neurotransmitters glutamate, acetylcholine (ACh), γ amino 
butyric acid (GABA), glycine, and a single serotonin receptor (Corringer et al., 
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2012; Millar and Harkness, 2008; Rosenberg et al., 2002). In mammals, LGIC 
family members can be broadly classified as either excitatory or inhibitory based 
on their permeability to either anions or cations. Ionotropic glutamate receptors 
(iGluR) and nicotinic acetylcholine receptors (nAChR) act as cation-selective 
channels and are excitatory, while GABA and glycine receptors act as anion-
selective channels and are generally inhibitory in the adult nervous system. Over 
40 distinct genes that encode subunits of LGICs have been identified in 
mammals (Baenziger and Corringer, 2011). These receptors are pentameric, 
with the exception of glutamate receptors which form tetramers, and are 
expressed in varying subunit combinations throughout the nervous system (Millar 
and Gotti, 2009). Pharmaceutical therapies designed to activate (agonists) or 
inhibit (antagonists) specific subunit combinations have been developed as 
potential treatments for diseases such as epilepsy and Parkinson’s (Brooks-
Kayal et al., 1998; Davies, 1995; Mulley et al., 2005; Quik and McIntosh, 2006). 
In Parkinson’s disease stimulation of presynaptic nAChRs can increase 
dopamine release in the substania nigra (Quik and McIntosh, 2006). Current 
treatments for Parkinson’s disease synthetically compensate for a loss of 
dopamine using L-DOPA, a precursor of dopamine. However, as previously 
mentioned in Parkinson’s models it is possible to achieve similar increases in 
dopamine levels by activating presynaptic nAChRs (Quik and McIntosh, 2006). 
nAChRs were the first members of the LGIC family to be isolated and studied in 
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vivo and much of our understanding of how LGICs function has come from 
studies of nAChRs (Unwin, 2005). 
Structure, function and localization of nicotinic acetylcholine receptors  
nAChRs were first isolated from the electric organ of the marine Torpedo 
ray and the Electrophorus eel (Changeux et al., 1970; Popot and Changeux, 
1984). In vertebrates, there are 17 nAChR subunits: α1-10, β1-4, δ, γ, and ε 
(Lindstrom, 2003; Millar and Harkness, 2008). In general, nAChRs fall into two 
classes, receptors comprised of identical subunits (homomeric) or different 
subunits types (heteromeric) (Unwin, 2005).The heteromeric nAChR of the NMJ 
contains the subunits α12β1δε; although, during development the subunit 
composition is slightly different (a γ subunit is substituted for an ε subunit) (Millar 
and Harkness, 2008).  In the nervous system the subunit composition of nAChRs 
has more potential for variability, enabling functional diversity across specific 
subunit combinations. Receptors formed from the alpha7 subunit (homologous to 
the ACR-16 subunit in C. elegans) are generally homomeric while the other 
subunits typically contribute to heteromeric receptors, the precise subunit 
combinations of which vary across neuronal classes. 
Each subunit of the pentameric nAChR contains four membrane spanning 
domains (Lindstrom, 2003). Activation of the channel occurs when ACh attaches 
to a binding site on the external face of the receptor. Initially, the extracellular N-
terminal region of α subunits was thought to be solely responsible for ligand 
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binding. However, more recent studies have shown that the ACh binding sites 
exist at the interface of adjacent subunits (Corringer et al., 2000; Luetje and 
Patrick, 1991). Proper formation of the ACh binding site is dependent on the 
presence of two adjacent cysteines located in the N-terminal region of α subunits 
(Figure 1-1) (Doyle, 2004; Lindstrom, 2003). Subunits without these adjacent 
cysteines are classified as non-alpha: β, δ, γ, and ε subunits. Each subunit has a 
large intracellular loop between the third and fourth transmembrane domains. 
The sequence of this intracellular loop does not appear to be highly conserved 
across other nAChR subunits of the same or different species (Doyle, 2004; 
Lindstrom, 2003). It is likely that sequence elements within the large intracellular 
loop are important for localization of the receptor.  
The second transmembrane domain of each subunit contributes to the ion 
channel pore of the receptor (Imoto et al., 1988; Revah et al., 1991). Mutations in 
specific residues of the pore region and the area directly surrounding the pore 
can dramatically alter kinetics, prolonging channel open time (Figure 1-2). For 
example, mutations at amino acids 234, 237 and 258 convert a channel from 
cationic to anionic. Residues 234 and 237 are located just outside the second 
transmembrane domain in the extracellular space while residue 258 is located at 
the intracellular end of the second transmembrane domain (Revah et al., 1991). 
Others have identified residues 236 and 251 as contributing to ion selectivity 
(Corringer et al., 1999; Galzi et al., 1992; Imoto et al., 1988). Reconstitution 
studies have shown the kinetics of α7 homomers could be dramatically altered by 
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mutating a residue in the second transmembrane domain. Mutating residue 247 
from a non-polar leucine to a polar serine has the most pronounced effect on 
mean channel open time (Revah et al., 1991). Hypersensitive nAChRs, or gain of 
function receptors, have since been used to examine the role of cholinergic 
signaling in the CNS. Using an α4 gain of function knock in mouse model, 
researchers were able to identify interactions of nAChRs and dopamine D2 
receptors in regulating cholinergic interneuron activity (Zhao-Shea et al., 2010). 
Mutations in the pore lining domain of α6 (α6L9’S) nAChR subunit identified 
α6α4β2* containing receptors as a key target for disorders associated with 
reduced dopamine release. The researchers were able to specifically link the 
behavioral deficits of α6L9’S animals to α6α4β2* containing receptors in dopamine 
releasing neurons in vivo (Drenan et al., 2010). Additional work with gain of 
function α6 subunits has demonstrated a role for β3 subunits in promoting the 
function of α6 containing receptors (Dash and Lukas, 2012).  
Role of cholinergic signaling in the nervous system 
In the CNS nAChRs are predominantly localized at presynaptic terminals, 
while postsynaptic nAChRs act in the peripheral nervous system to mediate 
transmission in the sympathetic ganglia (Rassadi et al., 2005). Cholinergic 
signaling coordinates neuronal activity in several manners. First, nAChRs located 
at presynaptic sites are important in modulating the release of neurotransmitter. 
For example, activation of presynaptic nAChRs on dopamine neurons increases 
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neurotransmitter release (Salminen et al., 2004). Second, activation of pre-
synaptic nAChRs can trigger neurotransmitter release in the absence of a 
propagated signal; bypassing upstream signaling (Vizi and Lendvai, 1999). Third, 
cholinergic signaling is linked to changes in gene expression (Chang and Berg, 
2001; Hu et al., 2002). Researchers have demonstrated that selective activation 
of nAChRs leads to the phosphroylation of CREB, a transcriptional coactivator, 
and changes in expression of the immediate early gene c-Fos. Fourth, nAChRs 
can directly activate neurons by localizing to postsynaptic sites. It is possible 
subunit diversity in nAChRs provides an opportunity for diverse roles for 
cholinergic signaling. 
Altered cholinergic signaling is implicated in the pathophysiology of 
epilepsy, Parkinson’s disease, Alzheimer’s disease, and in addiction to nicotine 
(Dineley, 2007; Gotti and Clementi, 2004; Quik and McIntosh, 2006; Steinlein et 
al., 2012). Activation of nAChRs in the reward pathways of the brain facilitates 
nicotine addiction. There are at least three distinct classes of nAChRs involved in 
nicotine addiction α4*, α6*, and α7. Specifically, nicotine binds to presynaptic α7 
receptors on glutamatergic neurons in the laterodorsal tegmentum (LTD) 
influencing neurotransmitter release onto dopaminergic neurons in the ventral 
tegmentum area (VTA). The dopaminergic neurons express two classes of 
nAChRs, α4β2*- and β2*- containing receptors, which modulate neurotransmitter 
release and increase in burst firing (Dani et al., 2001; Mansvelder and McGehee, 
2002). Inhibitory GABA neurons also make synaptic contacts with dopaminergic 
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neurons of the VTA  and express α4β2 containing receptors (Dani and Harris, 
2005). However, distinct nAChRs extend beyond the reward pathways of the 
brain. α3β4 receptors were recently identified as directly mediating excitation of 
mitral cells from olfactory inputs. Activation of mitral cells filters the inputs from 
olfactory neurons (D'Souza and Vijayaraghavan, 2012). Additionally, impaired 
cholinergic signaling in Alzheimer’s disease results in decreases in cognition 
(McGehee et al., 1995). Mutations in α4 and β2 subunits have been linked to 
autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) (Raggenbass and 
Bertrand, 2002). There are age and dementia associated changes in high and 
low affinity nAChRs in various regions of the brain (Nordberg et al., 1992). During 
development, loss of α7 containing receptors dramatically reduces the number of 
glutamatergic synapses in the adult brain. The reduction in glutamatergic 
synapses is associated with the behavioral changes in α7 knockout mice 
including attention deficits and impaired spatial discrimination (Lozada et al., 
2012).  
C. elegans as a model for studying nervous system function 
C. elegans is an ideal invertebrate model for addressing fundamental 
principles of nervous system function. There are a host of cell specific drivers 
and the cell fate of all embryonic cells is known (Hobert, 2005). The genome of 
the organism has been fully sequenced and there is a myriad of genetic tools 
available, as well as readily available deletion mutants for many genes of 
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interest. Under laboratory conditions, C. elegans strains are maintained with a 
readily available bacterial food source so the animals do not have to move in 
order to feed. In addition, C. elegans are hermaphroditic so coordinated motor 
behaviors are not required for reproduction. These features allow one to 
propagate strains carrying severe mutations in genes required for nervous 
system function that would be lethal in most systems, and study the functional 
roles of these genes. In addition, the transparent body enables in vivo 
visualization of fluorescent markers in the intact animal. More recently developed 
techniques have made C. elegans amenable to electrophysiological experiments, 
which can be performed both in vivo and in vitro (Christensen et al., 2002; 
Francis et al., 2003; Richmond and Jorgensen, 1999). In addition, tools such as 
cell specific expression of light-activated ion channels, Channelrhodopsin-2 or 
Halorhodopsin, allow for the targeted activation of specific neuronal circuits in 
vivo and subsequent analysis using behavior and electrophysiology (Nagel et al., 
2005; Zhang et al., 2007a). Qualities of the animal’s characteristic sinusoidal 
movement can be measured under a variety of conditions. These tools allow 
researchers to tease apart how a single neuronal circuit contributes to a specific 
behavior.  
The C. elegans nervous system uses many of the same neurotransmitters 
as mammals including acetylcholine, GABA, and glutamate. The genome is 
about 97 megabases and contains over 19,000 genes (Consortium, 1998). This 
genome has a high density of receptors important for synaptic function. In 
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addition, there are on the order of 90 neurotransmitter-gated ion channels of 
which there are more than 30 potential nAChR subunits (Bargmann, 1998; Jones 
et al., 2007; Jones and Sattelle, 2004). C. elegans possess the largest known 
family of AChRs (Mongan et al., 2002). These subunits fall into six different 
groups named for the first subunit identified in each group: unc-29, unc-38, acr-8, 
acr-16, deg-3, and orphan LGIC (Figure 1-3). Specifically, the acr-8 and deg-3 
groups are unique to C. elegans (Jones and Sattelle, 2004). The acr-8 group has 
a unique feature compared to the other groups with a basic (histidine) residue in 
place of a highly conserve acidic (glutamate) residue in the second 
transmembrane domain of the receptor. This alteration can alter the ion 
selectivity from cation to anion (Corringer et al., 1999; Imoto et al., 1988). The C. 
elegans nAChR subunits are classified as either α (ligand binding) or non-α (non-
ligand binding) by the absence or presence of adjacent cysteines. Similar to 
mammalian subunits, C. elegans nAChRs show differential expression patterns 
and are not limited to a specific neuron class (Barbagallo et al., 2010; Cinar et 
al., 2005; Drenan et al., 2008; Fox et al., 2005; Jospin et al., 2009; Nordberg et 
al., 1992; Salminen et al., 2004).  
Genes involved in the trafficking of AChRs include Calnexin, BiP, unc-50, 
ric-3, and unc-74 (Boulin et al., 2008; Eimer et al., 2007; Forsayeth et al., 1992; 
Gelman et al., 1995). Both Calnexin and Bip are ER chaperones involved in the 
synthesis of nAChRs and are shed in the maturation process (Forsayeth et al., 
1992; Gelman et al., 1995). Unfolded or misassembled subunits are retained in 
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the ER and degraded by ER-associated degradation (Christianson and Green, 
2004). UNC-50 is specifically required for the trafficking of levamisole sensitive 
AChRs (L-AChRs). These proteins are involved in subunit specific trafficking of 
nAChRs, while the function of unc-74 remains unknown (Eimer et al., 2007). RIC-
3 is a protein important for the trafficking of nAChR, but not other LGIC, to the 
cell membrane and is localized to the endoplasmic reticulum (ER) (Halevi et al., 
2002). This is similar to the human form of ric-3 (hric3); however, the human form 
has further evolved to inhibit certain subunit combinations of nAChR and extend 
its regulation to other LGIC (Halevi et al., 2003). Taken together this evidence 
suggests factors involved in trafficking and localization are key regulators in 
preventing aberrant receptors from reaching the cell membrane. In addition, 
there are functional properties associated with distinct subunit compositions such 
as agonist sensitivity and calcium permeability (Changeux et al., 1970; Deneris et 
al., 1991; Drisdel and Green, 2000; Lipovsek et al., 2012). The C. elegans 
locomotory circuit is enriched for nAChRs making this circuit of alternating 
movement ideal for examining coordinated activity. 
Generating alternating movements in C. elegans 
Utilizing alternating movements as a model for identifying mechanisms 
that coordinate excitation and inhibition is common (Eklof-Ljunggren et al., 2012; 
Gabriel et al., 2011; Grillner and Jessell, 2009; Kupfermann and Weiss, 2001; 
Masino and Fetcho, 2005). One of the primary advantages to this model is a 
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completely defined network of neurons including the anatomical connections of 
all chemical and electrical synapses (White et al., 1986). The locomotory circuit is 
comprised of command interneurons, excitatory, and inhibitory motor neurons. 
Sensory information is relayed through command interneurons that synapse onto 
excitatory motor neurons. There are 5 sets of command interneurons: AVA, AVB, 
AVE, AVD, and PVC (White et al., 1986). AVA, AVE, and AVD regulate 
backwards movement through electrical and chemical synapses with the A motor 
neurons (backwards movement). AVB and PVC regulate forward movement via 
gap junctions and chemical synapses with B type motor neurons (forward 
movement) (Chalfie et al., 1985; Wicks et al., 1996; Zheng et al., 1999). Recent 
work has suggested gap junctions between AVA and A motor neurons function to 
bias the motor circuit towards forward versus backward movement. In addition 
electrical coupling may be modulatory in forward movement or there are 
alternative signaling mechanisms maintaining the communication between AVB 
and B type motor neurons in forward movement (Kawano et al., 2011). In turn, 
the excitatory motor neurons (A and B), form dyadic synapses with body wall 
muscle (BWM) initiating contraction while simultaneously activating inhibitory 
motor neurons. Activation of the inhibitory motor neurons initiates relaxation of 
the contralateral BWM. The simultaneous signaling of excitation and inhibition on 
opposing muscle groups is thought to be important for generation of the animal’s 
characteristic sinusoidal wave form (Figure 1-4) (White et al., 1986).  
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In vertebrates there are fundamental differences in NMJ and CNS 
synapses. First NMJ synapses are far more stable than those of the CNS which 
have a higher degree of plasticity. During development, the half life of receptors 
at the NMJ are lengthened unlike the receptors of the CNS. Second, the 
formation of CNS synapses occurs on the time scale of hours whereas the time 
scale at the NMJ is weeks (Holtmaat and Svoboda, 2009). Third, proteins 
associated with NMJ formation (i.e. Agrin, MuSK, and LRP4) are not required for 
CNS synapse formation. Lastly, in stark contrast to the CNS synapses the NMJ 
is regulated primarily by one neurotransmitter and one class of nAChR 
(Lindstrom, 2003). In the CNS neurons are polyinnervated, receiving both 
inhibitory and excitatory neurotransmitters (Kim et al., 2008; Zhang et al., 2008). 
The C. elegans NMJ is similar in that it is also polyinnervated, expresses different 
classes of receptors, and forms through mechanisms independent of Agrin, 
MuSK, and LRP4 (Francis et al., 2005; Richmond and Jorgensen, 1999; 
Touroutine et al., 2005) . Therefore, identifying molecular mechanisms involved 
in regulating the activity of the C. elegans locomotory circuit will be relevant for 
linking findings to mechanisms in the mammalian CNS.  
Within the C. elegans locomotory circuit are previously characterized 
nAChRs. One receptor is a homomeric (contains one subunit type) receptor 
containing five Acetylcholine Receptor-16 (ACR-16) (Francis et al., 2005; 
Touroutine et al., 2005) subunits, and a second receptor is heteromeric 
comprised of UNC-29, LEV-1, LEV-8, UNC-38, and UNC-63 subunits (Culetto et 
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al., 2004; Fleming et al., 1997; Unwin, 2005). The UNC-29, UNC-38, and UNC-
63 subunits are all essential for the function of the UNC-29 receptor. LEV-1 and 
LEV-8 are considered non-essential subunits. Similar to mammalian CNS 
synapses the inhibitory NMJ is mediated by a GABA receptor (UNC-49). This is 
in contrast to the mammalian NMJ which is regulated solely by nAChR. 
Formation of the C. elegans NMJ requires proteins such as CAM-1, a receptor 
tyrosine kinase, responsible for the proper trafficking of ACR-16 receptors 
(Fleming et al., 1997). CAM-1 is orthologus to the mammalian ROR1 and 2 
(Francis et al., 2005; Jensen et al., 2012). Furthermore, LEV-10 is a single pass 
transmembrane protein with several CUB domains which has been implicated in 
receptor clustering at the C. elegans NMJ (Gally et al., 2004). The mechanisms 
introduced here generate the characteristic alternating movement of C. elegans. 
The locomotory circuit of C. elegans is one of many models of alternating 
movement being utilized for understanding nervous system function. 
Alternating movement models in characterizing mechanisms of neuronal activity 
Walking vertebrates or swimming fish are classic demonstrations of the 
precision required to maintain the balance of excitatory and inhibitory signaling in 
movement circuits. Alternating movement can be seen in a host of organisms 
ranging from humans to C. elegans. Opposing muscle groups coordinate their 
activation and relaxation in order to properly time the shortening of one group of 
muscles while simultaneously lengthening the contralateral muscle group. 
16 
 
Alternating movements are finely modulated to achieve a variety of speeds, 
direction, amplitude, and frequency. Similar to the neuronal circuits in the brain, 
alternating movements require molecular mechanisms to facilitate adaptation to 
stimuli with a high degree of precision while maintaining a coordinated balance of 
excitation and inhibition. The molecular mechanisms that regulate activity in 
alternating movements are easier to study than those of the mammalian central 
nervous system. This is due in part to the well defined circuitry providing a more 
controlled environment for identifying and characterizing mechanisms of neuronal 
activity. This model circuit is an ideal alternative to the complex neuronal circuitry 
of the mammalian brain.  
Motor circuits have been characterized in several model systems including 
lamprey, zebrafish, mouse, and nematode (Goulding, 2009). The lamprey and 
zebrafish model systems have a unique feature of maintaining the complexity of 
highly connected interneuron populations while limiting the density of neurons 
(Eklof-Ljunggren et al., 2012; Masino and Fetcho, 2005). Comparing interneuron 
populations across species makes circuit analysis in vertebrate models more 
broadly relevant (Fetcho et al., 2008). Vertebrates allow us to address questions 
of how specific subsets of interneurons or motor neurons affect alternating 
movements and what kinds of molecular mechanisms are involved. However, 
invertebrate models present their own advantages for probing locomotory 
circuits. First, the circuitry is vastly simplified compared to vertebrate models 
(Altun, 2008; Jing and Weiss, 2002; Kupfermann and Weiss, 2001). Second, as 
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previously mentioned the connectivity of all neurons and synapses are identified 
and well characterized (Serrano et al., 2007; White et al., 1986). Third, the 
generation time of some invertebrate model organisms profoundly shorter than 
the generation time of vertebrate models. For example, the generation time of C. 
elegans is only 4 days. This allows researchers to perform large forward genetic 
screens and isolate mutants much faster than that of alternative model systems. 
Ultimately, the C. elegans locomotory circuit is ideally suited for linking 
mechanisms of neuronal activity to those of the mammalian CNS. 
Dissertation Overview 
My thesis work will focus on the chemical synapse, specifically how 
receptors regulate neuronal activity and directly influence behavior. I use the 
locomotory circuit of C. elegans as a model for identifying mechanisms that 
coordinate neuronal activity. The molecular mechanisms are critical to the 
balance of excitation and inhibition. The elucidation of these mechanisms will 
provide insights into mammalian nervous system function. In order to understand 
and study nervous system function it is important to be familiar with the types of 
molecular mechanisms that affect neuronal activity. Here in the first chapter I 
have introduced the structure and function of the nervous system including both 
chemical synapses and electrical coupling. I have also provided background on 
mechanisms that regulate neuronal activity and specifically the role of cholinergic 
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signaling in regulating neuronal activity. I have ended with establishing C. 
elegans as an informative model for studying nervous system function.  
 Chapter II identifies a mechanism important in directly coordinating 
excitatory and inhibitory signaling in the C. elegans locomotory circuit. Here, I 
provide evidence that a single nAChR subunit, ACR-12, forms two distinct 
classes of nAChRs. These distinct classes have differential localization, 
composition, and roles in regulating behavior. Our previous work with acr-2 
identified a heteromeric nAChR expressed in cholinergic motor neurons (ACR-
2R) (Barbagallo et al., 2010). The ACR-2R has diffuse localization in the 
dendrites and a modulatory role in regulating neuron activity (Barbagallo et al., 
2010; Jospin et al., 2009). Loss of ACR-2Rs results in subtle changes in behavior 
(see Appendix). In contrast the recently identified GABA neuron-specific ACR-12 
(ACR-12R) localizes to discrete sites within the dendrites. Colocalization of these 
discrete sites opposed to a presynaptic reporter suggests ACR-12R is synaptic. 
Since two of the subunits from the ACR-2R are not expressed in GABA neurons, 
this observation suggests that GABA neuron-specific ACR-12 containing 
receptors are distinct from the heteromeric cholinergic receptor. In addition, the 
ACR-12R is implicated in regulating the consistency of the C. elegans waveform 
and mediating the activity of GABA neurons under conditions of elevated 
acetylcholine (ACh) release. Taken together, these results suggest diverse roles 
for receptor subtypes are important for coordinating neuronal activity.  
19 
 
Chapter III identifies the contributions of neuronal subsets to the 
generation of movement. Data in this chapter demonstrates that expression of a 
gain of function ACR-12 [ACR-12(V/S)] receptor has dramatic effects on behavior 
including highly reduced movement and spontaneous convulsions. In addition, 
expression of this transgene leads to the degeneration of the GABAergic nervous 
system, but not the cholinergic nervous system. These degenerative effects can 
be observed at early life stages and preliminary evidence suggests this 
degeneration is cell autonomous.  Interestingly, the NMJ inhibitory receptor, 
UNC-49, remains unaffected by the degeneration of presynaptic GABA neurons. 
Our results indicate ACR-12(V/S) will be a useful tool in identifying how subsets 
of neurons contribute to the overall behavior of an animal. Lastly, expression of 
ACR-12(V/S) may prove a useful genetic tool for identifying proteins associated 












Figure 1-1 reprint from (Doyle, 2004). The structure of a nAChR. 
(a) An extracellular perspective of the transmembrane helical topology in its 
closed state. (b). A side view (γ subunit removed). For all subunits (2α, β, and δ), 
transmembrane (TM) TM1 (red), TM2 (magenta), TM3 (green) and TM4 (blue). 
Residues of the hydrophobic gate are modeled in yellow ball-and-stick. TM2 





















Figure 1-2 reprint from (Revah et al., 1991): “b, Functional properties of α7 
receptor mutants. b, Normalized currents evoked by 100μM ACh in Xenopus 
oocytes expressing α7 wild type (WT) and α7 L247F, L247V, L247T, L247S, 
L246T, S248A receptors (where letters represent amino acids at positions given 
by the numbers) are superimposed. The normalized responses to ACh from WT, 







Figure 1-3 (Jones and Sattelle, 2004): Phylogeny of C. elegans nAChR 
subunits with vertebrate AChR subunits and other members of the LGIC 
superfamily. C. elegans α subunits (blue), non-α subunits (red), and GABA, 
glycine, glutamate, 5-HT3 and vertebrate nAChR subunits (black). Cosmid 











Figure 1-4 (Altun, 2011). Schematic of C. elegans locomotory circuit. Dark and 
light green shading indicates body wall muscles. In blue are the ACh MNs (VA, 
VB, DA, DB, AS, VC) and orange indicates GABA MNs (VD and DD). Axons and 
dendrites of ventrally directed cholinergic motor neurons (ventral A and ventral B 
classes) extend through the ventral nerve cord. Dorsally directed cholinergic 
motor neuron cell bodies (dorsal A class and dorsal B classes) are located 
adjacent to the ventral nerve cord and extend axons into the dorsal nerve cord, 
where they make dyadic synaptic contacts with body wall musculature and 






Excitation and inhibition are coordinated 
through multiple cholinergic (nicotinic) 






Heterogeneity in the composition of neurotransmitter receptors is thought to 
provide functional diversity that may be important in patterning neural activity and 
shaping behavior (Dani and Bertrand, 2007; Sassoe-Pognetto, 2011). However, 
this idea has remained difficult to evaluate directly due to the complexity of 
neuronal connectivity patterns and uncertainty about the molecular composition 
of specific receptor types in vivo. Here we dissect how molecular diversity across 
receptor types contributes to the coordinated activity of excitatory and inhibitory 
motor neurons in the nematode Caenorhabditis elegans. We show that excitatory 
and inhibitory motor neurons express distinct populations of ionotropic 
acetylcholine receptors (iAChR) requiring the ACR-12 subunit. The activity level 
of excitatory motor neurons is influenced through activation of nonsynaptic 
iAChRs (Barbagallo et al., 2010; Jospin et al., 2009). In contrast, synaptic 
coupling of excitatory and inhibitory motor neurons is achieved through a second 
population of iAChRs specifically localized at postsynaptic sites on inhibitory 
motor neurons. Loss of ACR-12 iAChRs from inhibitory motor neurons leads to 
reduced synaptic drive, decreased inhibitory neuromuscular signaling and 
variability in the sinusoidal motor pattern. Our results provide new insights into 
mechanisms that establish appropriately balanced excitation and inhibition in the 
generation of a rhythmic motor behavior, and reveal functionally diverse roles for 





The pattern of activity in neuronal circuits is the basis for behavior, addition, 
learning and memory (Dani and Harris, 2005; Gotti and Clementi, 2004; Steinlein 
et al., 2012). Identifying the mechanisms responsible for this patterning will 
provide insights into how behaviors are readily adaptable with a constantly 
changing environment. The ligand-gated ion channel family is broadly expressed 
throughout the nervous system and is a major contributor to neuronal patterning 
(Doyle, 2004; Lindstrom, 2003). While many of the receptor families and 
individual subunits have been identified, the functional consequences for 
heterogeneity among individual receptor families remain unclear. Functional 
diversity remains difficult to evaluate directly due to the complexity of neuronal 
connectivity patterns and the uncertainty about the molecular composition of 
specific receptor types in vivo. Differences in subunit composition have been 
linked to changes in localization and kinetic properties of the receptors (Glykys 
and Mody, 2007; Imoto et al., 1988; Revah et al., 1991; Teichert et al., 2012; 
Zhang et al., 2007b). These changes can have profound effects on neuronal 
activity. Therefore, understanding how molecular diversity among individual 
receptor families gives rise to functional diversity and alters neuronal activity will 
be important for understanding normal brain physiology and the pathophysiology 
of disorders that affect post-synaptic receptors.  
In C. elegans, excitatory cholinergic motor neurons (ACh MNs) make 
synaptic contacts onto both muscle cells and GABA MNs that, in turn, make 
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inhibitory synaptic contacts onto opposing musculature (Figure 2-3A) (White et 
al., 1986). Proper function of this circuit produces temporally coordinated and 
balanced excitatory and inhibitory signals that pattern movement. While the 
anatomical connectivity of this circuit has been well characterized, the signaling 
mechanisms that underlie coordinated motor neuron activity are not well 
understood. Expression studies have revealed that many of the 29 ionotropic 
acetylcholine receptor subunits encoded by the C. elegans genome are 
expressed in motor neurons, suggesting that cholinergic signaling may play a 
prominent role (Cinar et al., 2005; Fox et al., 2005; Jones et al., 2007; Rand, 
2007). For example, cholinergic motor neurons express a class of heteromeric 
acetylcholine-gated ion channel complexes known as ACR-2R (Barbagallo et al., 
2010; Jospin et al., 2009). ACR-2Rs are ionotropic receptors of the nicotinic 
acetylcholine receptor superfamily composed of five distinct subunits (ACR-2, 
ACR-3, UNC-38, UNC-63 and ACR-12), each of which is essential for function in 
heterologous expression studies. Loss of ACR-2R leads to relatively subtle 
changes in behavior; however, gain-of-function acr-2 mutations (acr-2(gf)) have 
profound consequences including hyperactivation and, in extreme cases, death 
of ACh MNs (Barbagallo et al., 2010; Jospin et al., 2009). In a forward genetic 
screen to identify mutations that suppressed the toxic effects of acr-2(gf) (ACR-
2L9'S), we isolated several loss-of-function alleles of a partnering acetylcholine 
receptor subunit, acr-12 (Barbagallo et al., 2010). Specific expression of acr-12 in 
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ACh MNs of animals coexpressing acr-2(gf) restored toxicity in acr-12 mutants, 
demonstrating a cell autonomous role for ACR-12 in these neurons.  
Here we identify and characterize a second class of ACR-12 containing 
receptors in GABA motor neurons (ACR-12R*). Animals that have lost GABA 
ACR-12Rs in GABA motor neurons exhibit inconsistency in body bend amplitude 
across consecutive body bends. Subcellular localization of GABA neurons ACR-
12R show discrete sites of green fluorescent protein (GFP) fluorescence. Using 
electrophysiology we show loss of acr-12 results in significant loss of inhibitory 
post synaptic events in the muscle that can be rescued with cell specific 
expression of ACR-12 in GABA neurons. Lastly, we demonstrate under 
conditions of elevated ACh release that acr-12 mutants can suppress the 
paralyzing effects of channelrhodopsin in upstream cholinergic motor neurons. 
Taken together our results provide valuable insights into the mechanisms of 
cholinergic signaling in nervous system function. 
MATERIALS AND METHODS 
C. elegans strains 
C. elegans strains were grown under standard laboratory conditions at 22°C. All 
strains are derivatives of the N2 Bristol strain (wild type). Transgenic strains were 
obtained by microinjection to achieve germline transformation. Multiple 
independent extragenic lines were obtained for each transgenic strain and data 
presented are from a single representative transgenic line unless noted 
otherwise. In all cases, lin-15(n765ts) mutants were injected with the lin-15 
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rescuing plasmid (pL15Ek; 30ng/ul) and one or more of the following plasmids: 
pPRB5 [Punc-47::mCherry], pPRB6 [Pacr-2::mCherry], pPRB47 [Pacr-
2::mCherry-RAB-3], pPRB53 [ACR-12-GFPICL], pPRB77 [Pacr-2::ACR-12-
GFPICL], pHP7 [Punc-47::ACR-12-GFPICL], pAG21 [ACR-12-GFPC-term]. Stably 
integrated lines were generated by X-ray integration and outcrossed at least four 
times to wild type. The following strains were used in this study: IZ914: acr-
12(ok367)X; IZ853: acr-12(ok367)X;ufIs57[ACR-12-GFPICL]; IZ984: acr-
12(ok367);ufIs78[Pacr-2::ACR-12::GFPICL]; IZ556: acr-12(ok367);ufIs92[Punc-
47::ACR-12-GFPICL]; IZ941: unc-49(e382)III;acr-12(ok367)X; IZ33: unc-
29(x29);acr-16(ok789); IZ514: unc-29(x29);acr-16(ok789);acr-12(ok367); IZ519: 
acr-12(ok367);ufIs23[Pacr-2::ChR2-GFP]; IZ801: ufIs23[Pacr-2::ChR2-GFP]; 
IZ629: ufIs38[ACR-12-GFPC-term];ufIs34[Punc-47::mCherry]; IZ651: ufIs38[ACR-
12-GFPC-term];ufIs43[Pacr-2::mCherry]; IZ632: ufIs26[Punc-
4::mCherry];ufIs38[ACR-12-GFPC-term]; IZ557: ufIs63[Pacr-2::mCherry-RAB-
3];ufIs92[Punc-47::ACR-12-GFPICL]; CB382: unc-49(e382)III; IZ712: acr-12(uf77); 
RB1559: acr-2(ok1887)II; IZ805: ufIs53[Punc-17::ChR2-mCherry]; IZ1096: acr-




The ACR-12-GFPICL transgene (pPRB53) was generated by cloning the GFP 
coding sequence in-frame into the sequence of an acr-12 genomic fragment (-
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1514 to +4799 bp relative to the translational start site) encoding the intracellular 
loop (ICL) between transmembrane domains (TM)3 and TM4. ACR-12-GFPICL 
was localized in neuronal processes and expression of this construct was 
sufficient for rescue of acr-12 mutants. pAG21 [ACR-12-GFPC-term] was provided 
by Alexander Gottschalk and was used in cell identifications (Fig. 1). ACR-12-
GFPC-term fluorescence was largely confined to cell bodies. Punc-47::ACR-12-
GFPICL (pHP7) and Punc-47::ACR-12-GFPICL (pPRB77) were generated by 
subcloning a 4.9 kb NruI/BglI fragment containing GFP from pPRB53 into 
constructs encoding the acr-12 cDNA under control of the appropriate promoters 
(pBB25 and pHP3 respectively). Punc-47::mCherry (pPRB5) was generated by 
subcloning mCherry coding sequence downstream of a 1.3 kb promoter for the 
unc-47 gene. Pacr-2::mCherry (pPRB6) was generated by subcloning a 3.3 kb 
promoter for the acr-2 gene upstream of the mCherry coding sequence.  
 
Microscopy 
Confocal microscopy was performed using a Zeiss Axioskop 2 microscope 
system and LSM Pascal 5 imaging software (Zeiss). All images used animals 24 
h after the L4 stage and were processed using ImageJ software. For all synapse 
quantification, a region of the dorsal cord directly across from the vulva was 
imaged. Synapses were quantified within a 50 μM region of interest by 
thresholding fluorescence intensity and using the “analyze particles” module in 
ImageJ software. The percentage of overlap with pre-synaptic RAB-3 was 
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determined by quantifying the number of mCherry::RAB-3 puncta which were 




All behavioral analyses were performed using staged populations of young adult 
animals (24 h following L4) at room temperature (22°C-24°C). Strains were 
scored in parallel, with the researcher blinded to the genotype during both 
experiment and analysis. For aldicarb assays, staged populations of adult 
animals (≥10) were transferred to NGM plates containing 1 mM aldicarb 
(ChemService), and movement was assessed every 15 min for 2 h. Movies and 
still images for behavioral analyses were obtained using an Olympus SZ61 
upright microscope equipped with a FireWire camera (Imaging Source). For body 
bend measurements, amplitudes were determined using ImageJ software. The 
distance between the deepest point of the bend and a line tangent to the tip of 
the head and the body was measured. This measurement was then normalized 
to the length of each animal and either averaged across 3 consecutive body 
bends to generate a value for average body bend amplitude (Figure 2-6D) or 10 
individual consecutive body bends (Figure 2-6B and C). For gross movement, 
individual worms were transferred to 100mm (large) unseeded plates. The 
number of body bends and spontaneous reversals were counted manually over 
1-minute intervals for 3-minutes and averaged (Figure 2-6E). For optogenetic 
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experiments, animals were maintained on OP50 plates containing retinal and 
450-490 nm light (2.5 mW/mm2) was delivered using an Exfo X-cite series 120 
light source and appropriate GFP excitation filters. On the day of the assay 
staged young adult animals were moved to a fresh plate for an equilibration 
period of 1 minute prior to filming for 40 s. After 10 s of filming the animals were 
exposed to blue light for 15 s and then filmed for an additional 10 s after blue 
light exposure. Responses were categorized using the following criteria: no 
movement impairment, tail bend ≤ 90°, tail bend > 90°, or arrested movement. 
Electrophysiology 
Endogenous postsynaptic currents were recorded from body wall muscles 
as previously described (Francis et al., 2005). The extracellular solution 
consisted of 150 mM NaCl, 5 mM KCl, 4 mM MgCl2, 1 mM CaCl2, 15 mM 
HEPES, and 10 mM glucose (pH 7.4, osmolarity adjusted with 20 mM sucrose). 
The intracellular fluid (ICF) consisted of 115 mM K-gluconate, 25 mM KCl, 0.1 
mM CaCl2, 50 mM HEPES, 5 mM Mg-ATP, 0.5 mM Na-GTP, 0.5 mM cGMP, 0.5 
mM cAMP, and 1 mM BAPTA (pH 7.4, osmolarity adjusted with 10 mM sucrose). 
For some experiments measuring GABA-mediated currents, the intracellular 
solution contained 115 mM KCl and 25 mM K-gluconate. At least 60-90 s of 
continuous data were used in the analysis. Data analysis was performed using 
Igor Pro (WaveMetrics, Inc.) and Mini Analysis (Synaptosoft, Inc.) software. 




Loss of ACR-12 leads to heightened excitability 
acr-12 encodes a 573 amino acid iAChR alpha subunit (Figure 1) with 
significant homology to the ACR-8 like group of C. elegans subunits and more 
distant homology to mammalian neuronal heteromeric alpha subunits such as 
alpha6 (Jones et al., 2007). To investigate the contribution of ACR-12 receptor 
complexes to the excitability of neurons in the motor circuit, we evaluated 
independent strains carrying putative loss of function alleles of acr-12 during 
acute exposure to the cholinesterase inhibitor aldicarb. Treatment of C. elegans 
with aldicarb leads to elevated levels of synaptic ACh and causes paralysis over 
time due to prolonged muscle contraction (Nguyen et al., 1995). The contractile 
state of muscles reflects the summed activity of excitatory ACh and inhibitory 
GABA synaptic inputs; genetic mutations that alter this balance will shift the time 
course over which aldicarb leads to paralysis. For example, manipulations that 
reduce or eliminate inhibitory GABA signaling cause enhanced muscle activation 
and more rapid paralysis (Loria et al., 2004; Vashlishan et al., 2008). acr-
12(uf77) was isolated as a suppressor of acr-2(gf) and is a missense mutation 
affecting a splice acceptor site that results in premature termination prior to 
transmembrane domain 4 (aa 387) (Barbagallo et al., 2010). acr-12(ok367) is a 
deletion mutation that eliminates 1368 bp of chromosomal DNA, including 
sequence encoding transmembrane domains 1-3 (Figure 2-1). Strains carrying 
either of these alleles were viable and gross connectivity of the nervous system 
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was normal (not shown), indicating that ACR-12 is not required for normal 
development of the nervous system. We found the acr-12(uf77) and acr-
12(ok367) mutations both accelerated the time course of aldicarb-induced 
paralysis (Figure 2-2A), suggesting loss of ACR-12 led to enhanced excitability. 
In contrast, previous work showed removal of ACR-2Rs slightly delayed paralysis 
in response to aldicarb treatment (Barbagallo et al., 2010; Jospin et al., 2009). 
The differential effects of aldicarb across acr-2 and acr-12 mutants suggested 
ACR-12 has additional roles in the nervous system independent of ACR-2. To 
better define potential functions for ACR-12 signaling, we constructed double 
mutants lacking both acr-12 and unc-49. The unc-49 gene encodes an essential 
subunit of ionotropic GABAA-like receptors at inhibitory neuromuscular synapses 
and mutations in unc-49 cause aldicarb hypersensitivity (Figure 2-2A) (Bamber et 
al., 1999; Vashlishan et al., 2008). unc-49;acr-12 double mutants exhibited no 
additional hypersensitivity beyond that of unc-49 single mutants, suggesting that 
acr-12 and unc-49 may act in the same pathway.  
acr-12 is reported to have broad expression in the nervous system 
(Gottschalk et al., 2005) but a precise description of the motor neuron classes 
that express acr-12 has remained unclear. To address this issue, we generated 
transgenic strains expressing ACR-12 tagged with GFP (green fluorescent 
protein) at the C-terminus together with a red fluorescent reporter (Pacr-
2::mCherry) labeling ACh motor neurons, and examined the cellular distribution 
of ACR-12-GFP in the ventral nerve cord. ACR-12-GFP fluorescence was 
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broadly visible in motor neuron cell bodies and partially overlapped with Pacr-
2::mCherry expression, confirming that acr-12 is expressed in cholinergic motor 
neurons (Figure 2-2D). In addition we coexpressed ACR-12-GFP with a red 
fluorescent protein reporter for the A class and VC motor neurons (Punc-
4::mCherry) and observed a partial overlap of ACR-12-GFP that did not include 
the VC neurons (Figure 2-2E). Fluorescence was also clearly visible in additional 
motor neurons along the ventral cord. To confirm the identity of these neurons, 
we imaged animals co-expressing ACR-12-GFP with a reporter labeling GABA 
neurons (Punc-47::mCherry) and observed overlapping fluorescent signals 
(Figure 2-2F). Our results indicate ACR-12 contributes to iAChRs expressed by 
both ACh and GABA motor neurons. Furthermore, the limited expression of 
some ACR-2R constituents to ACh MNs strongly suggests the iAChR 
populations expressed by ACh and GABA motor neurons are molecularly distinct 
(Barbagallo et al., 2010; Jospin et al., 2009). 
To dissect functional roles for ACR-12 across motor neuron classes, we 
specifically expressed ACR-12 in either ACh or GABA motor neurons of acr-12 
mutants and tested the responses of these animals to aldicarb treatment (Figure 
2-2B). Specific expression of acr-12 in ACh MNs did not alter the aldicarb 
hypersensitivity and paralysis of acr-12 mutants. In contrast, specific expression 
of acr-12 in GABA neurons restored wild type sensitivity to aldicarb. Our results 
suggest that postsynaptic ACR-12 receptor complexes regulate GABA motor 
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neuron activity and inhibitory neuromuscular signaling under conditions when 
ACh levels are elevated. 
 
iAChRs requiring ACR-12 have distinct patterns of localization and 
functional roles across motor neuron classes 
We examined the subcellular distribution of ACR-12 in motor neurons by 
expressing a rescuing ACR-12-GFP fusion protein under control of the native 
promoter (Figure 3B). ACR-12-GFP expression was clearly visible in motor 
neuron processes of both the ventral and dorsal nerve cords of adult animals, 
and exhibited two contrasting patterns of fluorescence. In the ventral nerve cord 
we observed regions of punctate and diffuse localization while, in the dorsal cord, 
we observed punctate fluorescence almost exclusively (Figure 2-3B). In contrast, 
specific expression of ACR-12-GFP in ACh MNs produced only diffuse 
fluorescence in the ventral nerve cord and no detectable fluorescent signal in the 
dorsal nerve cord (Figure 2-3C). Axons and dendrites of ventrally directed 
cholinergic motor neurons (ventral A and B classes) extend through the ventral 
nerve cord. Cholinergic motor neurons innervating dorsal musculature (dorsal A 
and B classes) extend axons into the dorsal nerve cord, where they make dyadic 
synaptic contacts with body wall musculature and dendrites of ventrally directed 
GABA motor neurons (ventral D class) (Figure 2-3A) (White et al., 1986). The 
diffuse localization of ACR-12 in ACh MNs is consistent with our previous finding 
that ACR-12 contributes to heteromeric receptor complexes (e.g. ACR-2R) 
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without obvious postsynaptic localization in these neurons (Barbagallo et al., 
2010). Specific expression of ACR-12-GFP in GABA MNs produced solely 
punctate fluorescence (Figure 2-3D). Many of these ACR-12-GFP puncta were 
located immediately opposed to regions of cholinergic motor neuron axons in 
which the synaptic vesicle marker mCherry-RAB-3 was concentrated (Figure 2-
4A-C) (Klassen and Shen, 2007; Mahoney et al., 2006). Our results provide 
evidence that ACR-12 complexes in GABA MNs are clustered in receptor fields 
located opposite presynaptic specializations of ACh MNs. 
 
GABA motor neuron expression of ACR-12 is required for normal levels of 
inhibitory synaptic activity 
To directly test the requirement for ACR-12 in regulating motor neuron 
activity, we used standard electrophysiology recording techniques to measure 
the frequency of synaptic events at the NMJ in vivo (Figure 2-5) (Francis and 
Maricq, 2006). We employed two independent strategies to distinguish between 
GABA and ACh post synaptic currents (PSCs): 1) Recordings were made under 
ionic conditions where GABA and ACh mediated events were separable based 
on the directionality of the currents (see Experimental Procedures for details) and 
2) We recorded from unc-29;acr-16 double mutants that are devoid of functional 
iAChRs on body wall muscles and lack excitatory neurotransmission at the NMJ 
[18, 19]. In both cases, we observed a significant reduction in the rate of 
endogenous GABA mediated inhibitory PSCs in mutants lacking ACR-12 
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receptors (53%, p<0.001 and 69 %, p<0.01 respectively) (Figure 2-5). We did not 
observe a significant difference in the amplitude of endogenous inhibitory PSCs 
(wild type, 26 ± 1.8 pA; acr-12, 23.4 ± 2 pA, p>0.05, Figure 5). To distinguish 
whether the reduction in inhibitory PSC frequency arose as a consequence of 
loss of ACR-12 from GABA MNs or arose due to reduced excitation levels in 
presynaptic ACh MNs, we recorded from animals that expressed acr-12 
specifically in ACh or GABA MNs (Figure 2-5). The reduced IPSC rate was 
partially rescued by expression of acr-12 in GABA motor neurons, while 
expression in ACh MNs was not sufficient for rescue. Additionally, the acr-12 
deletion mutation did not significantly reduce the rate or amplitude of 
endogenous excitatory PSCs (wild type, 28.6 ± 1.8 pA; acr-12, 26.8 ± 1.3 pA, 
p>0.05), although we did note a trend toward reduced frequency (33%, p = 0.07) 
(Figure 2-5E). Thus, the reduction in endogenous IPSC frequency cannot be 
explained by decreased excitation of presynaptic ACh MNs. Our results indicate 
that independent populations of ACR-12 receptors act cell autonomously in ACh 
and GABA MNs to regulate their activity. 
 
ACR-12 mediated signaling onto motor neurons regulates locomotion 
To determine how ACR-12 mediated signaling onto motor neurons 
contributes to normal locomotory behavior, we tracked animals during 
exploratory movements on agar plates. The sinusoidal locomotory wave 
appeared more erratic in acr-12 animals (Figure 2-6A). To examine this in more 
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detail, we monitored consecutive body bends during extended periods of 
uninterrupted forward movement (Figure 2-6A and B). Wild type animals 
displayed remarkable consistency in their movement with only a few irregularities 
in their sinusoidal tracks. In the absence of ACR-12 receptors (ok367 and uf77), 
the motor pattern was less stable, showing significantly increased variability in 
body bend amplitude from one body bend to the next (Figure 2-6C, p<0.001). 
Furthermore, acr-2(ok1887) mutants do not have an irregular waveform 
suggesting loss of GABA-specific ACR-12 iAChRs is required for coordination of 
a consistent waveform. Animals expressing a genomic ACR-12-GFP reduced 
variability to wild type levels (Figure 2-6C green). In addition to an inconsistent 
waveform we observe a modest reduction in the average amplitude of body 
bends (~14% for both uf77 and ok367, p<0.05 and p<0.01 respectively) (Figure 
2-6D). Body bend amplitude was reversed by ACR-12 expression using the 
native promoter. In addition, specific expression of ACR-12 in GABA motor 
neurons, but not cholinergic motor neurons reversed the reduction in body bend 
amplitude. Moreover, acr-2(ok1887) mutants did not exhibit changes in body 
bend amplitude. These disruptions in body bend variability and amplitude likely 
contribute to the overall decrease acr-12(ok367) mutant movement (Figure 2-
6E). In addition to changes in the number of body bends over time acr-12(ok367) 
mutants also exhibit an increase in the frequency of spontaneous reversals 
(Figure 2-6E). This increase may indicate important roles for ACR-12 iAChRs in 
the interneurons. Here we highlight how ACR-12 receptors under laboratory 
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conditions mediate subtle attributes of locomotory patterning leading to changes 
in the overall number as well as the quality of those body bends. 
 
ACR-12 receptors mediate GABA neuron activity under elevated conditions 
of ACh release. 
To investigate how synaptic activation of ACR-12 receptors on GABA MNs 
contributes to motor control under elevated levels of ACh release, we expressed 
the light-activated ion channel channelrhodopsin (ChR2) in A and B class ACh 
MNs (ufIs23) that make direct synaptic contacts onto GABA MNs. Wild type 
animals expressing ChR2 exhibited a behavioral response to light stimulation 
that was largely invariant from animal to animal (Figure 2-7A). Immediately 
following the onset of simulation, animals typically slowed or paused forward 
movement and initiated muscle contraction in the posterior portion of the body. 
More prolonged exposure (>~5 s) led to a complete cessation of forward 
movement for the duration of the stimulation period and a characteristic bending 
of the tail (Figure 2-7B). Normal forward movement could be reinitiated 
immediately following optogenetic stimulation and these effects were completely 
dependent on the presence of exogenous retinal (Figure 2-7B and C). Head 
movements were unimpaired throughout the stimulation period, presumably 
because the acr-2 promoter does not provide for efficient expression in motor 
neurons that synapse onto head and neck muscles (Barbagallo et al., 2010; 
Jospin et al., 2009). These observations suggest that photostimulation of wild 
45 
 
type animals impaired movement through synchronous depolarization of ACh 
MNs and simultaneous activation of both body wall muscles and GABA MNs 
along the length of the body. We found that loss of ACR-12 receptors 
ameliorated this effect (Figure 2-7C and D, ACh MN only (Pacr-2), p<0.0001). 
acr-12 mutants expressing ChR2 were able to execute sinusoidal body bends 
and maintain coordinated movement even during prolonged periods of light 
exposure (15-20 s). Thus, loss of ACR-12 receptors diminishes the intensity of 
the behavioral response to synchronous ACh MN depolarization. As ACR-12 
receptors are located on GABA MNs that are directly postsynaptic to the 
photoresponsive ACh MNs, our results suggest that synaptic drive onto GABA 
MNs is reduced in acr-12 mutants and that synchronous excitation of GABA MNs 
is critical for the behavioral response to optical stimulation. Furthermore, acr-
2(ok1887) mutants showed no suppression of the ChR2 effect (Figure 2-7C and 
D). When we express ChR2 with a cell specific promoter for all cholinergic motor 
neurons (ufIs53) we see dramatic changes in behavior that acr-12(ok367) 
mutants do not suppress (Figure 2-7C and E). However, simultaneously 
activating all cholinergic motor neurons may activate alternative neuronal circuits 
that feed back into GABAergic neurons through other signaling mechanisms 
such as neuropeptides or G-protein coupled receptors. 
DISCUSSION  
Characterizing functional diversity among receptor families will provide 
insights into signaling mechanisms that maintain a well balanced circuit. 
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Conditions that arise from a shift in the balance of excitation and inhibition have 
profound effects on behavior. For example changes in GABAA receptor 
composition have been linked to patients with epilepsy, a seizure disorder. 
Specifically, α1β3γ2 receptors are replaced by α4β3γ2 receptors in the 
extrasynaptic regions of the thalamus and hippocampus (Lagrange et al., 2007). 
Additionally, this alteration in subunit composition augments the kinetics of the 
receptor which correlates with susceptibility to seizures (Lagrange et al., 2007). 
Furthermore, in some cases of temporal lobe epilepsy there is a down regulation 
of the δ subunit and an increase in α4 and γ2 subunits in peri-synaptic regions of 
the dentate gyrus. These altered receptors negatively affect tonic inhibitory 
currents (Zhang et al., 2007b).    
We show here that subunit composition also affects receptor function in 
the C. elegans motor circuit. At least 2 classes of iAChRs requiring ACR-12 
participate in shaping activity of this circuit. While receptors on cholinergic motor 
neurons appear diffusely distributed and may act to maintain appropriate levels 
of activation through an extrasynaptic mechanism (Barbagallo et al., 2010; 
Jospin et al., 2009), receptors located on GABA neurons appear positioned at 
synapses to mediate direct coupling of excitatory and inhibitory motor neurons. 
At least two subunits of iAChRs present on ACh MNs (ACR-2R*) are not 
expressed in GABA MNs (Jospin et al., 2009), implying that distinct receptor 
subunit combinations are expressed by each motor neuron class. The two 
localization patterns we observed may arise from differences in subunit 
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composition of the receptor or differential expression of localization factors 
unique to each motor neuron subtype. Further characterization of the iAChR 
constituents in GABA MNs will be key to addressing this important question, as 
well as understanding potential effects of differing biophysical properties across 
receptor types. Interestingly, iAChRs play similarly diverse roles in the 
mammalian nervous system where they are primarily postsynaptic at autonomic 
synapses and primarily presynaptic or extrasynaptic in the brain (Dani and 
Bertrand, 2007). 
Our experiments also reveal the presence of additional signaling pathways 
onto GABA MNs that function independently of ACR-12 receptors. GABA IPSCs 
continued at a reduced rate in acr-12 mutants, indicating GABA MN activity 
persists even when synaptic drive from ACh MNs is reduced. Consistent with this 
result, the absence of ACR-12 receptors led to variability in the locomotory wave 
but did not disrupt gross movement or lead to phenotypes similar to that of 
mutants in which GABA signaling is absent (McIntire et al., 1993). Finally, under 
conditions of elevated ACh release, as is the case with the photostimulation 
experiments, we showed the behavioral response to synchronous depolarization 
of ACh MNs was altered in acr-12 mutants. This suggests that the reduced 
synaptic coupling of ACh and GABA MNs in acr-12 mutants allows GABA MNs to 
function independently of synchronously active ACh MNs during 
photostimulation. Under these conditions, the timing of GABA MN activation may 
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be coordinated either by timing mechanisms intrinsic to GABA MNs or through 
activity of other neurons not expressing ChR2 that lie presynaptic to GABA MNs. 
C. elegans locomotion is a dynamic and remarkably complex behavior. 
While the anatomical connectivity of the C. elegans nervous system was 
described over 30 years ago, we have only recently been able to reconcile this 
static picture of nervous system wiring with measures of functional connectivity 
(White et al., 1986). One of the barriers to progress in understanding the neural 
circuit mechanisms responsible for the generation of movement has been an 
inability to independently manipulate ACh and GABA MNs. For example, 
mutations that alter the activity of ACh MNs also impact synaptically coupled 
GABA MNs. The identification of signaling molecules, like ACR-12, responsible 
for mediating functional connectivity between these neuron classes will be 
essential in our continuing efforts to understand how coordinated excitation and 
inhibition in this circuit gives rise to a stable motor pattern. The presence of 
diverse signaling mechanisms in the control of motor neuron excitability may 
provide for behavioral flexibility in the face of changing levels of neuronal activity 
or environmental conditions. Support for this idea comes from the recent 
characterization of behaviorally important G-protein coupled receptor populations 
present on motor neurons, indicating additional levels of fine control (Chase et 
al., 2004; Dittman and Kaplan, 2008; Schultheis et al., 2011). Identification of the 
comprehensive set of relevant molecular signals and their physiological roles will 
enable detailed analyses of how functional differences across signaling 
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molecules contribute to signal integration by neurons, neural circuit function and 










Figure 2-1 ACR-12 gene sequence.  (A) acr-12 amino acid sequence. cys-loop 
(*), vicinal cysteines present in alpha subunits (^^), GFP insertion site (green 
box), transmembrane domains (blue boxes), ok367 deletion (red lettering), uf77 
mutation (yellow box). Sequences are from GeneBank (B) Schematic of ACR-12 
receptor subunit with approximate locations of annotations from A. cys-loop (*), 
vicinal cysteines present in alpha subunits (^^), GFP insertion site (green box), 
transmembrane domains (M1-4), ok367 deletion (red shading), uf77 mutation 












Figure 2-2 ACR-12 iAChRs regulate GABA motor neuron activity. 
(A) Time course of paralysis in the presence of aldicarb (1 mM) for wild type 
(blue) [n=11], acr-12(ok367) mutants (red) [n=12], acr-12(uf77) mutants (gray) 
[n=8], unc-49(e382) mutants (brown)[n=11], and acr-12(ok367);unc-49 double 
mutants (dark green) [n=10], and ACR-12-GFP rescue using the native promoter 
(green) [n=12]. Data represent mean ± SEM. n=the number of experiments done 
with at least 10 animals per experiment. (B) Time course of aldicarb (1 mM) 
paralysis for wild type (blue) [n=13], acr-12(ok367) mutants (red) [n=14], ACh-
specific (Pacr-2) ACR-12-GFP rescue (purple) [n=10], and GABA-specific (Punc-
47) ACR-12-GFP rescue (black) [n=10]. (C) Diagram of C. elegans ventral nerve 
cord. Blue box indicates the region imaged in D-F. (D) Confocal image showing 
coexpression of ACR-12-GFP (ufIs38) and a cholinergic motor neuron-specific 
marker (ufIs43) in the posterior ventral nerve cord. For D-F, asterisks indicate cell 
bodies co-expressing reporters and scale bars indicate 50 µm. (E) Confocal 
image showing coexpression of ACR-12-GFP (ufIs38) and a GABA-specific 
marker (ufIs34) in the posterior ventral nerve cord. (F) Confocal image showing 
coexpression of ACR-12-GFP (ufIs38) and a Punc-4::mCherry (ufIs26) in the 





Figure 2-3  
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Figure 2-3 ACR-12 is differentially localized across motor neuron populations. 
(A) Schematic of C. elegans locomotory circuit. Dark green shading indicates 
ACh MNs (VA, VB, DA, DB) and light green indicates GABA MNs (DD and VD). 
Dark blue and light shading represent body wall muscles. Figure modified from 
WormAtlas.  (B) Confocal images of ACR-12-GFP localization in ventral and 
dorsal nerve cords as indicated (ufIs57). For B-D, scale bar indicates 10 µm. (C) 
Confocal image of ACR-12-GFP (ufIs78) localization in ACh MNs of the posterior 
ventral nerve cord. (D) Confocal images ACR-12-GFP (ufIs92) localization in 












Figure 2-4 ACR-12 is localized at synapses on GABA motor neurons. (A) 
Confocal image of a 50 µm region of the dorsal nerve cord showing 
colocalization of mCherry-RAB-3 expressed in cholinergic motor neurons (ufIs63) 
with ACR-12::GFP expressed in GABA MNs (ufIs92). All images are oriented 
with the tail to the right and scale bar represents 10μM. (B, C) Bar graphs 
showing the average number of ACR-12 and RAB-3 puncta and percentage 











Figure 2-5. Loss of ACR-12 receptors reduces inhibitory signaling. (A) 
Representative recordings of endogenous inhibitory PSCs recorded at 0 mV for 
the indicated genotypes. Rescue refers to acr-12 mutants expressing ACR-12 
under control of either the unc-47 (GABA) or acr-2 (ACh) promoters. (B) Average 
endogenous IPSC frequency for the genotypes indicated. WT, n=7; acr-12, n=10; 
acr-12 rescue (GABA), n=6; acr-12 rescue (ACh), n=4. For (B) and (D-E), error 
bars show SEM. *p<0.01. (C) Representative recordings of endogenous 
inhibitory PSCs recorded at -60 mV for the indicated genotypes. Recordings 
were made using 115 mM KCl in the pipette. (D) Average endogenous IPSC 
frequency for the genotypes indicated. unc-29;acr-16, n=12; unc-29;acr-16;acr-
12, n=11. (E) Average excitatory PSC frequency for the genotypes indicated. 
WT, n=17; acr-12, n=21. (F) Representative recordings of endogenous excitatory 
PSCs recorded at -60 mV for the indicated genotypes. Also refer to supplemental 








Figure 2-6 (continued)  
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Figure 2-6 ACR-12 receptors are required for consistent motor patterning. (A) 
Still images of locomotory paths for wild type and acr-12(ok367) mutants as 
indicated. Tracks are marked by white dashed lines. Scale bars indicate 2 mm. 
(B) Body bend amplitudes for 10 consecutive body bends of four representative 
animals of the indicated genotype plotted relative to average body bend 
amplitude. Gray shading indicate separate animals. (C) Coefficient of variance 
for body bend amplitude averaged over ten consecutive body bends for wild type 
(blue) [n=23] animals, acr-12(ok367) (red) [n=18], acr-12(uf77) (gray) [n=11], 
ACR-12-GFP rescue with native promoter (green) [n=11], acr-2(ok1887) (black) 
[n=13]. Asterisks indicate significant difference from wild type: acr-12(ok367) 
p<0.0001, acr-12(uf77) p<0.0001. (D) Scatter plot of body bend amplitudes for 
wild type, acr-12(uf77), acr-12(ok367), and rescue strains as indicated.  Wild type 
(blue) [n=45], acr-12(uf77) mutants (gray) [n=31], acr-12(ok367) mutants (red) 
[n=52], ACh-specific (Pacr-2) ACR-12-GFP rescue (purple) [n=20], GABA-
specific (Punc-47) ACR-12-GFP rescue (orange) [n=20], genomic rescue (green) 
[n=20], acr-2(ok1887) (black) [n=24].Each point represents an average of three 
consecutive body bends for an individual animal. Mean ± SEM is indicated by 
horizontal lines.  Asterisks indicate significant difference from wild type: acr-
12(ok367) p<0.01, acr-12(uf77) p<0.02, ACh specific rescue p<0.05. (E) Bar 
graphs of the average number of body bends and average number of 
spontaneous reversals of wild type (blue) [n=20], acr-12(ok367) (red) [n=20], and 
genomic rescue (green) [n=10] animals. Asterisks indicate significant difference 
from wild type: average movement acr-12(ok367) p<0.0001, average 















Figure 2-7 GABA neuron-specific ACR-12 receptors mediate elevated levels 
ACh signaling. (A) Schematic depicting experimental protocol for 
photostimulation experiments. Asterisks indicate timing of still images shown in 
B. (B) Still images showing representative responses of wild type animals and 
acr-12 mutants expressing ChR2 (ufIs23) at the times indicated. Asterisks 
indicates posterior bend. (C) Quantification of percentage of animals responding 
to photostimulation of cholinergic motor neurons (ACh MN) (left) and all 
cholinergic neurons (ACh) (right). Asterisks indicate significant difference from 
ChR2 (ACh MN) p<0.0001. (D) Distribution of response to photostimulation of 
cholinergic motor neurons (ufIs23, ACh MN) types using the descriptive 
behavioral classifications indicated. ChR2+retinal [n=74], ChR2;acr-
12(ok367)+retinal [n=43], ChR2;acr-2(ok1887)+retinal [n=73], ChR2 no retinal 
[n=36], ChR2;acr-12(ok367) no retinal [n=28], ChR2;acr-2(ok1887) no retinal 
[n=27]. (E) Distribution of response to photostimulation of all cholinergic neurons 
(ufIs53) types using the descriptive behavioral classifications indicated. For C-E 
the sample sizes are as follows: ChR2+retinal [n=63], ChR2;acr-
12(ok367)+retinal [n=51], ChR2 no retinal [27], ChR2;acr-12(ok367) no retinal 
[n=27]. For D and E no retinal controls are not shown as there were no 







A sensitized nAChR leads to spontaneous 
contractions and GABA neuron toxicity in 






Behavior is shaped by the precise coordination of activity in neuronal 
circuits. Recent findings utilizing sensitized nicotinic acetylcholine receptors 
(nAChRs) have provided valuable insights into mechanisms of regulating 
neuronal activity. Here we engineer a gain of function ACR-12 [ACR-12(V/S)] 
transgene to identify specific roles for neuronal subsets in generating the 
sinusoidal movement of C. elegans. We previously demonstrated a similar gain 
of function subunit in ACR-2R, specifically the acr-2 subunit, resulted in neuronal 
toxicity and cell death (Barbagallo et al., 2010). However, transgenic ACR-
12(V/S) expression resulted in the generation of spontaneous contractions and 
dramatically reduced movement. We were able to use cell specific drivers to 
identify the cholinergic motor neurons as sufficient to generate spontaneous 
contractions. Activation of DA and DB neurons did not have an obvious affect on 
movement or on the generation of contractions. Unexpectedly, we found 
expression of ACR-12(V/S) results in cell autonomous degeneration of GABA 
neurons. This degeneration has no obvious impact on downstream inhibitory 
NMJ receptors. Here we demonstrate sensitized nAChRs as a useful tool in 
identifying mechanisms of neuronal circuit activity in adapting behavior. Further 
development of ACR-12(V/S) and similar tools will enable genetic approaches to 
identify modifiers of nAChR signaling as well as investigation of the molecular 
pathways underlying differential susceptibility of neuronal populations to ion 






Subtle changes in the activity of neuronal circuits can profoundly shape 
behavior. The nervous system adapts behavior through the precise coordination 
of both excitatory and inhibitory signaling. Identifying the molecular mechanisms 
that regulate neuronal activity is important for understanding how balanced 
signaling is achieved and behavior is adapted. The inappropriate activation of 
neuronal circuits can have profound negative effects including disorders such as 
epilepsy, Parkinson’s, and addiction (Dani and Harris, 2005; Drenan et al., 2008; 
Futatsugi and Riviello, 1998; Quik and McIntosh, 2006). Ionotropic receptors are 
a functionally diverse family of ion channels activated by neurotransmitters to 
facilitate neuronal activity. Much of our understanding of their structure and 
function is derived from the first receptor to be isolated and studied, nicotinic 
acetylcholine receptors (nAChR) (Changeux et al., 1970; Popot and Changeux, 
1984).  
Characterization of nAChRs identified the second transmembrane (TM2) 
domain as lining the ion channel pore (Gotti and Clementi, 2004; Unwin, 2005). 
Mutations in specific residues of the pore region and the area directly 
surrounding the pore can dramatically alter kinetics, prolonging channel open 
time, desensitization (Figure 1-3), and ion selectivity. Reconstitution studies 
revealed the kinetics of mammalian homomeric α7 nAChRs were dramatically 
altered by mutating a residue in the second transmembrane domain (Galzi et al., 
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1991; Imoto et al., 1988; Revah et al., 1991). Mutating residue 247 from a non-
polar leucine to a polar serine has the most pronounced effect on mean channel 
open time (Revah et al., 1991). Hypersensitive or gain-of-function nAChRs have 
since been used to examine the role of cholinergic signaling in the CNS. Using 
an α4 gain of function knock in mouse model, researchers were able to identify 
interactions of nAChRs and dopamine D2 receptors in regulating cholinergic 
interneuron activity (Zhao-Shea et al., 2010). Mutations in the pore lining domain 
of α6 (α6L9’S) nAChR subunit identified α6α4β2* receptors as a key target for 
disorders associated with reduced dopamine release. The researchers were able 
to specifically link the behavioral deficits of α6L9’S animals to α6α4β2* receptors in 
dopamine releasing neurons in vivo (Drenan et al., 2010). Additional work with 
gain of function α6 subunits has demonstrated a role for β3 subunits in promoting 
the function of α6 containing receptors (Dash and Lukas, 2012). 
Here we use a similar strategy to explore the function of nAChRs in the C. 
elegans locomotory circuit. The C. elegans locomotory circuit is an attractive 
model for probing mechanisms that regulating opposing signaling. In C. elegans, 
excitatory cholinergic motor neurons (ACh MNs) make synaptic contacts onto 
both muscle cells and GABA MNs that, in turn, make inhibitory synaptic contacts 
onto opposing musculature (Figure 1-4) (White et al., 1986). Proper function of 
this circuit produces temporally coordinated and balanced excitatory and 
inhibitory signals that pattern movement. While the anatomical connectivity of this 
circuit has been well characterized, the signaling mechanisms that underlie 
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coordinated motor neuron activity are not well understood. Expression studies 
have revealed that many of the 29 ionotropic acetylcholine receptor (iAChR) 
subunits encoded by the C. elegans genome are expressed in motor neurons, 
suggesting that cholinergic signaling may play a prominent role in regulating 
movement (Cinar et al., 2005; Fox et al., 2005; Jones et al., 2007; Rand, 2007). 
Finally, the nematode nervous system uses many of the same neurotransmitters 
as mammals including acetylcholine, GABA, and glutamate.<--This doesn’t really 
fit with the rest 
Previous studies have shown that cholinergic motor neurons express a 
class of heteromeric acetylcholine-gated ion channel complexes known as ACR-
2R (Barbagallo et al., 2010; Jospin et al., 2009). ACR-2Rs are ionotropic 
receptors of the nicotinic acetylcholine receptor superfamily composed of five 
distinct subunits (ACR-2, ACR-3, UNC-38, UNC-63 and ACR-12), each subunit 
of which is essential for function in heterologous expression studies (Jospin et 
al., 2009). Loss of ACR-2R leads to relatively subtle changes in behavior; 
however, gain-of-function acr-2 mutations have profound consequences 
including hyperactivation and, in extreme cases, death of ACh MNs. In addition 
to the ACR-2R we have identified the role of a second class of nAChRs 
containing the ACR-12 subunit (ACR-12R). These receptors are localized to 
synapses of GABA neurons and maintain consistency of body bend movements 
(see Chapter 2).  
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Here, using cell specific promoters and a gain of function approach we 
have isolated behaviors specific to subsets of motor neurons. In addition, we 
show that subsets of motor neurons appear selectively vulnerable to toxicity 
caused by expression of a gain of function ACR-12 receptor. 
EXPERIMENTAL PROCEDURES 
C. elegans strains 
C. elegans strains were grown under standard laboratory conditions at 22°C. All 
strains are derivatives of the N2 Bristol strain (wild type). Transgenic strains were 
obtained by microinjection to achieve germline transformation. Multiple 
independent extragenic lines were obtained for each transgenic strain and data 
presented are from a single representative transgenic line unless noted 
otherwise. In all cases, lin-15(n765ts) mutants were injected with the lin-15 
rescuing plasmid (pL15Ek; 30ng/ul) and one or more of the following plasmids: 
pPRB5 [Punc-47::mCherry], pPRB53 [ACR-12-GFPICL] (intracellular loop), 
pPRB77 [Pacr-2::ACR- 12-GFPICL], pHP7 [Punc-47::ACR-12-GFPICL], pPRB59 
[ACR-12(V/S)::GFP], pPRB65 [Punc-47::ACR-12(V/S)::GFP], pPRB79 [Pacr-
2::ACR-12(V/S)::GFP], and pHP8 [Punc-129::ACR-12(V/S)::GFP]. Stably 
integrated lines were generated by X-ray integration and outcrossed at least four 
times to wild type. The following strains were used in this study: IZ914: acr-
12(ok367)X; IZ853: acr-12(ok367)X;ufIs57[ACR-12-GFPICL]; IZ984: acr-
12(ok367);ufIs78[Pacr- 2::ACR-12::GFPICL]; IZ556: acr-12(ok367);ufIs92[Punc-




12(V/S)::GFP]; IZ1058: ufIs102[Punc-47::ACR-12(V/S)::GFP]; IZ1077: acr-
12(ok367);ufIs111[Punc-129::ACR-12(V/S)::GFP]; IX697: acr-12(ok367);acr-
2(ok1887);ufIs90[ACR-12(V/S)::GFP]; RB1559: acr-2(ok1887); IZ324: acr-









The ACR-12-GFPICL transgene (pPRB53) was generated by cloning the GFP 
coding sequence in-frame into the sequence of an acr-12 genomic fragment (-
1514 to +4799 bp relative to the translational start site) encoding the intracellular 
loop (ICL) between transmembrane domains (TM) TM3 and TM4. ACR-12-
GFPICL was localized in neuronal processes and expression of this construct was 
sufficient for rescue of acr-12 mutants. Punc-47::ACR-12-GFPICL (pHP7) and 
Punc-47::ACR-12-GFPICL (pPRB77) were generated by subcloning a 4.9 kb 
NruI/BglI fragment containing GFP from pPRB53 into constructs encoding the 
acr-12 cDNA under control of the appropriate promoters (pBB25 and pHP3, 
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respectively). The ACR-12(V/S)-GFP was generated using Qiagen’s site directed 
mutagenesis kit. Point mutation was confirmed using enzymatic digest and 
subsequent sequencing. The cell specific versions were generating using the 
same cloning as the previously mentioned wild type versions. Punc-47::mCherry 
(pPRB5) was generated by subcloning mCherry coding sequence downstream of 
a 1.3 kb promoter for the unc-47 gene. 
 Microscopy  
Confocal microscopy was performed using a Zeiss Axioskop 2 microscope 
system and LSM Pascal 5 imaging software (Zeiss). Epifluorescent imaging was 
performed using a Zeiss Axioimager M1 microscope and Axiovision software 
(Zeiss). All images of adult animals used staged animals 24 h after the L4 stage 
and were processed using ImageJ software. For the developmental timeline, 
synchronized populations were obtained by bleaching gravid animals on NGM 
plates seeded with OP50. The resulting progeny were allowed to mature at room 
temperature. Animals were imaged at 16, 28, 38, and 48 h after bleaching using 
wide-field epifluorescent microscopy. 
Behavioral assays  
All behavioral analyses were performed using staged populations of young adult 
animals (24 h following L4) at room temperature (22°C-24°C). Strains were 
scored in parallel, with the researcher blinded to the genotype during both 
experiment and analysis. For aldicarb assays, staged populations of adult 
animals (≥10) were transferred to NGM plates containing 1 mM aldicarb 
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(ChemService), and movement was assessed every 15 min for 2 h. Movies and 
still images for behavioral analyses were obtained using an Olympus SZ61 
upright microscope equipped with a FireWire camera (Imaging Source). For 
gross movement, individual worms were transferred to 100mm (large) unseeded 
plates. The number of body bends were counted manually over 1-minute 
intervals for 3-minutes and averaged. Spontaneous contractions were assessed 
observing individual worms on large seeded plates. The number of contractions 
were counted manually over 1-minute intervals for 3-minutes and averaged. For 
stimulated contractions animals were individually assessed on large plates 
seeded with OP50. Animals were stimulated five times at 30s intervals using an 
eyelash on the tip of the nose and then the average was calculated as a 
percentage of response per five stimulations. 
Results 
 
ACR-12(V/S) has dramatic consequences for behavior 
 
The C. elegans genome encodes 29 nAChR subunits that contribute to 
the formation of unique classes of homo- and hetero- pentameric receptors 
(Jones et al., 2007; Rand, 2007). Six of these nAChR subunits form two classes 
of nAChRs expressed in body wall muscle cells and are required for 
neuromuscular signaling (Francis et al., 2005; Richmond and Jorgensen, 1999; 
Touroutine et al., 2005). Previous work from our lab and others has shown that 
the expression of several nicotinic acetylcholine receptor subunits, including the 
α subunit acr-12, is enriched in motor neurons of the ventral nerve cord (see 
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Chapter 2) (Barbagallo et al., 2010; Cinar et al., 2005; Hallam et al., 2000; Jospin 
et al., 2009).  
To explore the role of ACR-12 in regulating motor neuron activity, we 
developed a gain-of-function strategy. The second transmembrane domains of 
Cys-loop family ligand-gated ion channel subunits line the ion channel pore and 
play a critical role in the properties of the channel (Galzi et al., 1991; Galzi et al., 
1992; Gotti and Clementi, 2004; Imoto et al., 1988) . Substitution of a polar amino 
acid (e.g., serine) for the non polar leucine at a highly conserved position within 
M2 (9’, so called because it is the 9th residue from the beginning of the 
membrane-spanning segment) produces a gain-of-function effect, resulting in 
increased receptor activation and very slow inactivation (Labarca et al., 1995; 
Revah et al., 1991). In the case of acr-12 this position also has a non polar 
residue, valine (Figure 3-1). We engineered a valine-to-serine point mutation into 
the sequence encoding the M2 9' position of an acr-12 rescuing construct to 
generate ACR-12(V/S) (Figure 3-1). Transgenic animals expressing an 
integrated ACR-12(V/S) array (ufIs90) in the acr-12(ok367) mutant background 
were used for all subsequent analyses. These animals are viable; however, are 
slightly delayed developmentally compared to wild type animals. Moreover, we 
noted obvious locomotory defects in transgenic ACR-12(V/S) animals (Figure 3-
2). These defects were observed across all larval stages including adult animals. 
Transgenic ACR-12(V/S) animals have a 75% reduction in body bends per 
minute compared to their wild type counterparts and a 50% reduction when 
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compared to acr-12 mutants (Figure 3-2B). ACR-12(V/S) animals exhibit a 
“shrinker” phenotype in response to touch along the body, similar to the response 
typical of GABA deficient mutants (Bamber et al., 1999). In addition to this 
phenotype, transgenic ACR-12(V/S) animals also exhibit spontaneous 
contractions (Figure 3-2A). These contractions are qualitatively similar to those 
previously described for a strain isolated in the Jin laboratory that carries a gain-
of-function acr-2 allele (Jospin et al., 2009). The dramatic changes in behavior as 
a result of ACR-12(V/S) expression suggest we can identify mechanisms for 
coordinating signaling and tease apart the contributions of subsets of motor 
neurons to movement.  
 
Cell specific expression of ACR-12(V/S) identifies specific roles for subsets 
of motor neurons 
Our previous work has shown ACR-12 to be broadly expressed in the 
nervous system (see Chapter 2). In order to tease apart mechanisms for 
coordinating movements and determine which subsets of motor neurons 
contribute to patterning movement, we used cell specific promoters to drive ACR-
12(V/S) expression in acr-12(ok367) mutants. We quantified movement by 
counting the number of body bends/minute. We found that animals expressing 
ACR-12(V/S) in cholinergic (ACh) motor neurons (Pacr-2) had improved 
movement compared to animals expressing ACR-12(V/S) under the endogenous 
acr-12 promoter (Figure 3-2). However this movement was not restored to wild 
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type levels, likely due to the presence of a secondary phenotype, spontaneous 
contractions. In contrast, movement in transgenic animals expressing ACR-
12(V/S) specifically in GABA neurons (Punc-47) was similar to that of acr-
12(ok367) mutants despite being in a wild type background (denoted with ‡ in 
Figure 3-2B). Movement of transgenic ACR-12(V/S) animals carrying a loss-of-
function allele (ok1887) of acr-2, an obligate subunit of the cholinergic ACR-12* 
receptor, was similar to acr-12 mutants. In this strain the ACR-12(V/S) is still 
present in GABA neurons with an acr-12 mutant background. This suggests 
GABA specific expression of ACR-12(V/S) does not significantly alter the speed 
of movement relative to acr-12 mutants. However, cell specific expression of 
ACR-12(V/S) in DA and DB neurons also reduces the movement to acr-
12(ok367) levels (Figure 3-2B). As previously mentioned, the excitatory 
cholinergic motor neurons (ACh MNs) make synaptic contacts onto both muscle 
cells and GABA MNs. These contacts are patterned across the ventral and 
dorsal musculature. One might expect simultaneous activation all dorsal ACh 
neurons to alter the precise timing of activation in body wall muscle. As a result 
we would expect an additional reduction in movement beyond that seen in the 
acr-12 mutant background.  
As noted above, the stimulated and spontaneous contractions we observe 
in ACR-12(V/S) animals are similar to those observed previously in a strain 
carrying an alternative acr-2(gf) allele (Jospin et al., 2009). In fact cell specific 
expression of ACR-12(V/S) in ACh motor neurons recapitulates these 
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contractions; while mutations in acr-2(ok1887) mutants suppressed the 
contractions (Figure 3-2). These results suggest the bilateral contraction of the 
body wall muscle we see upon ACh motor neuron-specific expression of ACR-
12(V/S) occurs when there is ACh build up along both dorsal and ventral body 
axis (Figure 3-2C and D). In contrast, cell-specific expression of ACR-12(V/S) 
solely in DA and DB motor neurons does not lead to spontaneous contractions. 
This may indicate that elevated levels of ACh directed along one axis of the body 
are not sufficient for the the generation of contractions. We did not see any 
spontaneous contractions with GABA specific expression of ACR-12(V/S). 
However there was a small increase (~20%) in the number of stimulated 
contractions (Figure 3-2C and D).  
 
Expression of ACR-12(V/S) leads to GABA motor neuron specific toxicity 
 Since we observed dramatic changes in behavior we wanted to confirm 
the health of the nervous system. To address this issue, we generated a 
transgenic strain co-expressing GFP (green fluorescent protein) in all of the ACh 
neurons (Punc-17::GFP), a red fluorescent reporter for GABA neurons (Punc-
47::mCherry), and the ACR-12(V/S) transgene under the endogenous acr-12 
promoter, and examined the ventral and dorsal cords. In wild type animals we 
observed clear separation of the two reporters and normal nervous system 
connectivity, including intact commissural projections that extended the length of 
the dorsal cord (Figure 3-3A). When we examined animals carrying the ACR-
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12(V/S) transgene we observed that the cholinergic nervous system appeared 
intact with no obvious differences compared to the wild type strain. In contrast, 
we observed dramatic changes in the structure of the GABA nervous system, 
including decreased numbers of GABA motor neurons, migration defects in the 
commisures, defasciculation of the ventral nerve cord, and large gaps in the 
dorsal nerve cord (Figure 3-3B). The degeneration of the GABA nervous system 
can be observed as early as L1 (Figure 4). The degree of degeneration varied 
across populations of ACR-12(V/S) animals. A few animals exhibited no 
degeneration while others were missing several GABA neurons and had almost 
no dorsal cord coverage. Loss of GABA neurons may explain why we observed a 
small number of stimulated shrinking events in animals expressing ACR-12(V/S) 
specifically in GABA neurons (Figure 3-2D).  
 
ACR-12(V/S) degeneration is a cell autonomous effect 
 The degeneration caused by ACR-12(V/S) expression could arise from 
three possibilities. First, the degeneration may be caused by over activation of 
the GABA neurons through elevated levels of ACh release from presynaptic 
cholinergic motor neurons. Second, ACR-12(V/S) expression in the GABA 
neurons may lead to prolonged activation of the channel resulting in tonic 
activation of GABA neurons and subsequent degeneration. Finally, toxicity of the 
neurons may arise from some combination of the first two scenarios. In order to 
identify the mechanism of toxicity, we expressed cell specific versions of ACR-
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12(V/S) with the previously mentioned reporters for ACh (Punc-17::GFP) and 
GABA (Punc-47::mCherry) neurons. Animals expressing the GABA specific 
ACR-12(V/S) and a GABA neuron reporter exhibited degeneration (Figure 3-5A 
and B). Animals co-expressing ACR-12(V/S) specifically in ACh motor neurons 
with a GFP reporter that labeled the entire cholinergic nervous system had no 
obvious difference from wild type animals (Figure 3-5). Similarly, the GABA 
nervous system appeared normal with expression of ACR-12(V/S) in ACh motor 
neurons (data not shown). These results indicate that degeneration of the GABA 
nervous system arises from cell autonomous expression of ACR-12(V/S) in the 
GABA neurons. 
 
UNC-49 receptors remain localized after GABA neuron degeneration 
 UNC-49 is the GABA receptor at the NMJ that mediates relaxation of 
contralateral body wall muscle. We wanted to investigate whether GABA motor 
neurons are required for maintenance of the post synaptic specialization. To test 
this we coexpressed a red fluorescent reporter (Punc-47::mCherry) for GABA 
neurons with a GFP reporter for UNC-49 receptors Figure 3-5C). In wild type 
animals we observed a clear distribution of GFP puncta along the dorsal cord 
apposed to the GABA neuron reporter. Interestingly, in ACR-12(V/S) animals we 
saw no obvious changes in UNC-49 puncta even in cases where we noted 
substantial defects in the number and/or connectivity of GABA motor neurons 
(Figure 3-5C). There are two possibilities for the normal localization of UNC-49 
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receptors. First, the presence of the GABA motor neurons may only be required 
for establishing post synaptic sites and not for the maintenance of the UNC-49 
receptor localization. Second, we cannot be sure how long presynaptic GABA 
neuron terminals have been absent from their normal site of innervation on body 
wall muscles, in which case there may not have been sufficient time for changes 




The development of sensitized nAChRs has provided researchers with 
new tools for identifying the mechanisms of cholinergic regulation of neuronal 
activity (Drenan et al., 2010; Galzi et al., 1991; Liu et al., 2012; Revah et al., 
1991). Reconstitution studies using gain of function receptors have provided 
insights into the functional contributions of specific subunits in receptors. For 
example, β3 subunits act to enhance the activity of α6* receptors (Dash and 
Lukas, 2012). Here we have engineered a gain of function mutation in the 
second transmembrane domain of ACR-12 containing receptors in order to 
identify mechanisms involved in coordinating the precise timing of alternating 
movements in C. elegans. Similar mutations in the pore lining domain of the 
mammalian α6 (α6L9’S) nAChR subunit identified α6α4β2* containing receptors as 
a key target for disorders associated with reduced dopamine release (Drenan et 
al., 2010). A α4 gain of function knock in mouse model identified interactions of 
nAChRs and dopamine D2 receptors in regulating cholinergic interneuron activity 
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(Zhao-Shea et al., 2010). We have demonstrated expression of a similar 
sensitized nAChR in C. elegans, ACR-12(V/S), leads to spontaneous bilateral 
contractions of body wall muscles. Cell specific drivers identified the cholinergic 
motor neurons as sufficient to recapitulate these contractions. Transgenic ACR-
12(V/S) animals carrying a deletion mutation in the acr-2 gene suppressed the 
spontaneous contractions. These results suggest the spontaneous contractions 
of ACR-12(V/S) arise from the activity of a receptor containing both ACR-2 and 
ACR-12 (ACR-2R) and not the presence of an aberrant nAChR.   
One might expect the spontaneous contractions to arise out of 
deregulated timing mechanisms in the circuit. Interference with the timed 
activation of cholinergic neurons, which drive the locomotory circuit, could be 
sufficient for generating locomotory phenotypes. However, animals expressing 
ACR-12(V/S) solely in dorsal cholinergic motor neurons did not exhibit 
spontaneous contractions. This suggests the bilateral excitation of body wall 
musculature from ACR-12(V/S) in all cholinergic motor neurons is required for 
spontaneous contractions. Furthermore, cell-specific expression of ACR-12(V/S) 
solely in dorsal cholinergic motor neurons did not lead to profound changes in 
movement (Figure 3-2). One reason for this could be the presence of the acr-
12(ok367) mutant background. Previous behavior analysis has revealed acr-12 
mutants have reduced body bends/minute compared to wild type and an 
inconsistent waveform (Chapter II). This mutant background could be masking 
subtle changes in movement as a function of ACR-12(V/S) expression in DA and 
83 
 
DB motor neurons. Nervous system development is not obviously affected by 
specific expression of ACR-12(V/S) in DA and DB neurons, and increased 
aldicarb sensitivity suggests these animals have increased ACh release.  
Unexpectedly we found cell specific expression of ACR-12(V/S) in GABA 
neurons produced toxicity and subsequent loss of GABA neurons. The toxicity 
was cell autonomous suggesting fundamental differences in the susceptibility of 
motor neuron populations to toxicity. This finding could provide valuable insights 
into the unique properties of GABA neurons. Perhaps GABA neurons express 
specific proteins that makes GABA neurons more sensitive to changes in activity. 
This toxicity was variable across animals and could be observed as early as L1 
animals. The cholinergic nervous system remained intact with no obvious 
changes in connectivity, while the GABA nervous system exhibit neuronal 
degeneration which was severe in some animals. The variability in degeneration 
may arise from specific activity requirements of subsets of neurons. Perhaps the 
more heavily active neurons during development are more susceptible to toxicity 
while other neurons with less activity demands are able to compensate for 
excess signaling. It will be interesting to see if the GABA neurons that are 
degenerating are of a specific class, VD or DD. During the transition from the first 
larval stage to the second larval stage (L2) the number of ventral nerve cord 
motor neurons increases substantially, with the addition of >50 motor neuron cell 
bodies (Sulston and Horvitz, 1977). The loss of GABA neurons has surprising 
effects on the postsynaptic receptors. 
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We found that despite the dramatic loss of dorsal cord coverage of GABA 
neurons the UNC-49 receptor remained localized to discrete sites along the 
dorsal cord. One might expect in the absence of presynaptic motor neurons the 
inhibitory post-synaptic receptor field would not develop properly. Alternatively, 
the receptor field may develop normally, but not be maintained and slowly 
degenerate over time. One possibility is that internalization or delocalization of 
receptors requires more time. From these experiments it is difficult to assess how 
long the presynaptic GABA neurons have been absent. Another possibility is 
once the NMJ has formed the proper localization of the excitatory NMJ receptors, 
ACR-16 and UNC-29, aid in maintaining UNC-49 localization.    
One might then expect these animals to exhibit phenotypes similar to the 
phenotypes of GABA deficient mutants. Similar to GABA deficit mutants GABA 
specific expression of ACR-12(V/S) resulted in aldicarb hypersensitivity (data not 
shown) and reduced movement. However, these transgenic animals exhibited a 
low occurrence of the shrinker phenotype associated with GABA deficient 
mutants such as unc-49(e382). One possibility is that the remaining GABA 
neurons expressing sensitized ACR-12(V/S) are enough to compensate for the 
increased excitation in the locomotory circuit. Another possibility is the sensitized 
ACR-12(V/S) receptor actually inhibits GABA neuron activity but the neurons still 
have residual tonic activity.  
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In conclusion, ACR-12(V/S) has provided us with the opportunity for 
characterizing timing mechanisms of cholinergic motor neurons in generating 
spontaneous contractions. Additionally ACR-12(V/S) has shown the GABA 
neurons to be more susceptible to ion channel-mediated toxicity compared to 
their cholinergic motor neuron counterparts. Moving forward it will be interesting 
to identify the mechanism underlying degeneration of GABA neurons, examine 
mechanisms for regulation of the inhibitory NMJ in more detail, and investigate 












Figure 3-1 Mutating in a conserved residue of ACR-12. (A) Alignment of the 
second transmembrane domain of ACR-12 (green), other C. elegans nAChR 
(yellow), and various mammalian subunits (blue). The site of the 9’ valine to 
serine gain-of-function mutation is indicated (red). Sequences from Genbank. (B) 
Schematic of ACR-12 receptor in cell membrane. Arrow indicates location of the 










Figure 3-2 ACR-12(V/S) animals exhibit dramatic behavioral deficits. (A) Still 
images showing representative spontaneous contractions of ACR-12(V/S) 
animals over a 7 second time interval. Black lines indicate original starting 
position of the nose and tail in t=0s still. Asterisks indicates posterior bend. (B) 
Bar graphs of the average number of body bends of ACR-12 Ox (genomic 
rescue) (white) [n=16], ACR-12(V/S);acr-12(ok367) (dark blue) [n=21], GABA-
specific (Punc-47) ACR-12(V/S) (orange) [n=19], DA/DB-specific (Punc-129) 
ACR-12(V/S) (light blue) [n=10], ACh MN-specific (Pacr-2) ACR-12(V/S) (black) 
[n= 19], ACR-12(V/S);acr-2(ok1887);acr-12(ok367) (red) [n=6], and acr-
2(ok1887) (grey) [n=10]. For reference † indicates number of body bends for wild 
type animals and ‡  acr-12(ok367) mutants (see chapter 2) (C, D) Bar graphs of 
the average number of spontaneous contractions and average number of 
stimulated contractions of wild type (white) [n=21], [n=45], ACR-12 Ox (genomic 
rescue) (white) [n=22], [n=22], ACR-12(V/S);acr-12(ok367) (dark blue) [n=33], 
[n=22], GABA-specific (Punc-47) ACR-12(V/S) (orange) [n=11] [n=27], DA/DB-
specific (Punc-129) ACR-12(V/S) (light blue) [n=11], [n=10], ACh MN-specific 
(Pacr-2) ACR-12(V/S) (black) [n= 23], [n=22], ACR-12(V/S);acr-2(ok1887);acr-
12(ok367) (red) [n=10], unc-49(e382) (purple) [n=25], [n=20], ACh-specific (Pacr-
2) ACR-12-GFP rescue (grey) [n=11], [n=11], GABA-specific (Punc-47) ACR-12-
GFP rescue (white) [n=11], [n=11], acr-2(ok1887); acr-2(ok1887);acr-12(ok367) 
(white [n=10]; acr-12(ok367) (white) [n=31], [n=43], and acr-2(ok1887) (white) 
[n=10], [n=10]. Sample sizes are listed where appropriate and respectively. For 
B-D genotypes in the acr-12(ok367) mutant background are indicated beneath 











Figure 3-3 Expression of ACR-12(V/S) is toxic in GABA motor neurons. (A) 
Confocal image of a wild type animal showing coexpression of a cholinergic 
motor neuron-specific marker (ufIs48, Punc-17::GFP), and a GABAergic specific 
marker (ufIs34, Punc-47::mCherry) in the ventral nerve cord. (B) Confocal image 
of an ACR-12(V/S);acr-12(ok367) (ufIs90) animal showing coexpression of a 
cholinergic motor neuron-specific marker (ufIs48), and a GABAergic specific 
marker (ufIs34) in the ventral nerve cord. Scale bars indicate 100 µm and 










Figure 3-4 ACR-12(V/S) toxicity is observable in L1 larva. (A) Epifluorescence 
image of a wild type L1 animal (16hrs) showing coexpression of a cholinergic 
motor neuron-specific marker (ufIs48), and a GABAergic specific marker (ufIs34) 
in the ventral nerve cord. (B) Epifluorescence image of an ACR-12(V/S);acr-
12(ok367) (ufIs90) L1 animal (16 hrs) showing coexpression of a cholinergic 
motor neuron-specific marker (ufIs48), and a GABAergic specific marker (ufIs34) 
in the ventral nerve cord. Scale bars indicate 50µm and animals are oriented with 










Figure 3-5 GABA-specific expression of ACR-12(V/S). (A) Confocal image of a 
wild type and GABA-specifc (Punc-47) ACR-12(V/S) (ufIs102) animals showing 
expression of a GABAergic specific marker (ufIs34) in the ventral nerve cord. (B) 
Confocal image of a wild type and GABA-specifc (Punc-47) ACR-12(V/S) 
(ufIs102) animals showing expression of a GABAergic specific marker (ufIs34) in 
the dorsal nerve cord. For A and B scale bar indicates 100 µm. (C) Confocal 
image of a wild type and GABA-specifc (Punc-47) ACR-12(V/S) (ufIs90) animals 
showing coexpression of a GABAergic specific marker (ufIs34) and UNC-
49::GFP (oxIs22) in the dorsal nerve cord. Scale bars indicate 50 µm. For A-C 











In this thesis I have explored the mechanisms that drive neuronal activity. 
Using the C. elegans locomotory circuit I have made several interesting 
discoveries. First, similar to the mammalian CNS, I have identified diverse roles 
for distinct nAChRs subtypes in regulating neuronal activity. Two distinct classes 
of ACR-12 containing receptors are expressed in cholinergic motor neurons and 
GABA neurons. The cholinergic ACR-2R* is diffusely localized in dendrites and 
has a modulatory role in regulating neuronal activity, whereas the GABA neuron 
nAChR, ACR-12R* is localized to synapses, maintains consistency in movement, 
and mediates GABA neuron activity under conditions of elevated ACh release. 
Second, similar mutations in different subunits of the same receptor have 
dramatically different consequences for neuronal activity, suggesting receptor 
composition is crucial for function. Expression of ACR-2(L/S) resulted in toxicity 
of cholinergic motor neurons and subsequent degeneration, while expression of 
ACR-12(V/S) resulted in no obvious changes in neuronal architecture but 
profound behavioral consequences. Third, behavior can be adapted by altering 
the activity of subsets of neurons within a circuit. Over-activation of cholinergic 
motor neurons leads to the generation of spontaneous contractions while over-
activation of GABA neurons resulted in decreased movement. Unexpectedly, I 
found that subsets of neurons within a circuit can exhibit differences in tolerances 
to over-active signaling. Interestingly, specific expression of ACR-12(V/S) in 
GABA neurons resulted in the loss of GABA neurons and commissural defects; 
in contrast, the integrity of the cholinergic nervous system was not obviously 
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affected. Lastly, I demonstrated that degeneration of subsets of neurons does not 
immediately affect postsynaptic receptors. Inhibitory NMJ UNC-49 receptors 
remained localized to discrete sites despite the absence of presynaptic GABA 
motor neurons. Taken together, this work provides exciting new insights into 
molecular mechanisms coordinating the activation of subsets of neurons in a 
circuit and the behavioral consequences.  
Importance of regulating neuronal activity 
 The brain is capable of processing large amounts of stimuli with subtle 
changes in neuronal activity that translates into modified behavior. Maintaining 
tight coordination of circuit activity is critical for appropriately modifying behavior. 
When the patterned activation of neurons is deregulated there are profoundly 
adverse effects on behavior. For example, epilepsy, addiction, autism, dementia 
and depression are associated with deregulated or inappropriately modified brain 
signaling (Calabresi et al., 2007; Dani and Harris, 2005; Dzhala et al., 2012; 
Futatsugi and Riviello, 1998; Nordberg et al., 1992; Quik and McIntosh, 2006). 
Epilepsy is a clear example of the consequences associated with unregulated 
neuronal activity. Patients with epilepsy have what is called a “hyperexcitable” 
brain. Basically, patients suffer from one of two possibilities: (1) an excess of 
excitatory signaling or (2) a loss of inhibitory signaling which mimics an increase 
in excitation (Futatsugi and Riviello, 1998; Mulley et al., 2005; Raggenbass and 
Bertrand, 2002). As a result these patients suffer from convulsions (e.g., 
absence, grand mal, or partial) that have the potential to cause permanent brain 
99 
 
damage or, in extreme cases, death. Current treatments involve synthetically 
compensating for unregulated signaling to restore the brain to a more balanced 
state (Calabresi et al., 2007; Haut et al., 2006; Lee et al., 1995; Luszczki, 2009). 
Identifying the sources of inappropriate signaling will provide better therapeutic 
targets for maintaining a balanced brain state. 
Advances in research have leaned on using models with dramatic 
cognitive defects to identify genes important for coordinating neuronal activity 
(Holmes and Zhao, 2008; Liu et al., 2012; Zhao-Shea et al., 2010). Yet, many 
fundamental questions about neuronal activity in physiological conditions remain 
unclear. For example, what are the molecules that regulate the timing of neural 
circuit activation and how is signaling between various neural circuits achieved? 
In order to adequately address how the nervous system functions, we have to 
focus on addressing these questions. It is critical that we identify the roles for 
ionotropic receptors in neuronal activity and how those changes in activity can 
affect signaling. We need to understand how activation of subsets of neurons is 
achieved and modifies behavior. Addressing these questions will provide 
valuable insights in our understanding of nervous system. 
Identifying the versatile roles of nAChRs in neuronal function—are distinct 
receptor compositions functionally relevant? 
A common feature of LGIC members such as GABA receptors or nAChRs 
is the diversity of subunits within the receptor family. This diversity suggests the 
subunit composition of fully formed receptors has functional significance. Within a 
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neuronal circuit individual neurons have specific roles in driving the activity of the 
circuit and the roles of each neuron can be very different. One possibility is 
diverse subunits fulfill the wide range of signaling requirements across the 
nervous system by forming distinct receptor types. Evidence of distinct receptor 
types suggests neuronal activity can be modified with a high degree of precision. 
In vertebrates, nAChRs are localized predominantly at pre-synaptic 
terminals, although there are post-synaptic nAChRs in the sympathetic ganglia 
and muscle (Lindstrom et al., 1991; Rassadi et al., 2005). There are 17 nAChR 
subunits: α1-10, β1-4, δ, γ, and ε (Lindstrom, 2003; Millar and Harkness, 2008) 
which combine to form a myriad of distinct receptors. Nicotine’s effects in the 
reward pathways are an excellent example of diverse roles for distinct nAChRs. 
Glutamatergic neurons that project to the ventral tegmentum area (VTA) contain 
pre-synaptic α7 containing subunits (α7*) (Millar and Gotti, 2009). These 
receptors act to increase excitation of post-synaptic dopamine neurons in the 
VTA. The dopamine neurons express α4β2* receptors that regulate the activity of 
neurons, and β2* containing receptors at presynaptic terminals to modulate 
release of neurotransmitter (Dani and Bertrand, 2007; Dani and Harris, 2005; Liu 
et al., 2012). In addition, inhibitory GABA neurons make synaptic contacts with 
the dopamine neurons in the VTA express α4β2* receptors. Each of these 
nAChR classes has different localization patterns and affinity for nicotine (Dani 
and Harris, 2005). The actions of nicotine on nAChRs in this circuit result in 
nicotine dependence.  
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Similar to vertebrate models I have demonstrated nAChR have diverse 
functions in regulating the activity of locomotory neurons in C. elegans. ACR-2R 
receptors are diffusely localized in the upstream cholinergic motor neurons and 
modulate activity of the neurons (Barbagallo et al., 2010; Jospin et al., 2009). 
However, ACR-12R in GABA neurons localize to synapses and function to 
maintain the consistency in the amplitude of body bends over long forward runs. 
Under elevated levels of ACh release, ACR-12R can directly regulate GABA 
neurons activity (see Chapter II). Evidence for the importance of subunit 
composition in determining receptor functional properties can be found at the C. 
elegans NMJ as well. Previous work has identified nAChRs that mediate 
signaling at the excitatory NMJ. The homomeric ACR-16 receptor is responsible 
for nearly 90% of the excitatory signal yet deletion of this receptor subunit 
produces no obvious phenotype (Francis et al., 2005; Francis and Maricq, 2006). 
In contrast, UNC-29 receptors make up the remaining 10% of excitatory signal 
and have a more obvious uncoordinated movement (Culetto et al., 2004; Francis 
et al., 2005; Touroutine et al., 2005). Taken together, the distinct classes of 
nAChR in C. elegans with diverse roles reinforce the concept that subunit 
composition is an important factor in determining how receptors regulate 
neuronal activity.  
It seems unlikely that subunit composition is established simply based on 
the expression profiles of the individual subunits. Expression profiling of neuronal 
subsets, including dopaminergic neurons in the substania nigra and mitral cells, 
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shows expression of more than 5 nAChR genes within a population (D'Souza 
and Vijayaraghavan, 2012; Salminen et al., 2004). Dopamine neurons of the VTA 
express at least two distinct classes of nAChRs both of which contain the β2 
subunits (Dani and Harris, 2005). Similar studies in C. elegans indicate the 
presence of at least three additional nAChR subunits, acr-9, acr-14, and lgc-11, 
in GABA neurons (Cinar et al., 2005; Fox et al., 2005). In preliminary 
pharmacological experiments, I observed that mutation of any of these genes led 
to a different effects compared to mutation of acr-12, suggesting these subunits 
are unlikely to be obligate partners in a GABA neuron specific ACR-12R (data 
not shown). Some nAChR subunits preferentially interact with other specific 
subunits. For example, in vertebrates β3 subunits preferentially associate with α6 
subunits (Alkondon and Albuquerque, 2001; Drenan et al., 2008; Salminen et al., 
2004). These data suggest there are mechanisms in place to determine the 
subunit composition of receptors. One possibility is that signaling motifs in the 
individual subunits regulate their interactions with other subunits. Another 
possibility is subsets of neurons express unique factors that establish appropriate 
subunit interactions. In the future these questions could be addressed by creating 
chimeric receptors. For example, it would be interesting to determine if swapping 
the large intracellular loop of a subunit that does not associate with ACR-12 with 
the intracellular loop of a subunit that does reconstitutes a functional receptor. 
Another approach would be to create knockouts of all the nAChRs expressed in 
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a subset of neurons and transgenically express the subunits of a receptor not 
found in that subset of neurons. 
The punctate expression of GABA neuron specific ACR-12R* provides an 
opportunity to examine mechanisms of localization. Using GFP screens or a 
candidate gene approach we could determine proteins important for the 
localization and clustering of ACR-12R*s. Another possibility is subunit 
composition is important for the localization of receptors. This would suggest the 
subunits unique to the two distinct ACR-12Rs are driving their differential 
localization. Answers to these questions await determination of the precise 
subunit composition of the ACR-12 receptor in GABA motor neurons.  
Identifying mechanisms that modify behavior—coordinating excitation and 
inhibition 
Behavior is generated by the coordinated activation of neuronal circuits. 
However, the mechanisms that regulate the coordination of circuit activity remain 
unknown. The development of sensitized nAChRs has provided researchers with 
new tools for identifying the mechanisms of cholinergic regulation of neuronal 
activity. Reconstitution studies with gain of function receptors have provided 
insights into the functional contributions of specific subunits in receptors. For 
example, β3 subunits act to enhance the activity of α6* containing receptors 
(Dash and Lukas, 2012). Here we have engineered a gain of function mutation in 
the second transmembrane domain of ACR-12 containing receptors in order to 
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identify additional mechanisms coordinating the precise timing of alternating 
movements in C. elegans. Similar mutations in the pore lining domain of 
mammalian α6 (α6L9’S) nAChR subunit identified α6α4β2* containing receptors as 
a key target for disorders associated with reduced dopamine release (Drenan et 
al., 2010). A α4 gain of function knock in mouse model identified interactions of 
nAChRs and dopamine D2 receptors in regulating cholinergic interneuron activity 
(Zhao-Shea et al., 2010). We have demonstrated that ACR-12(V/S) animals 
exhibit spontaneous contractions. Cell specific drivers identified the cholinergic 
motor neurons as sufficient to recapitulate these contractions. Transgenic ACR-
12(V/S) animals carrying a deletion for acr-2 have suppressed spontaneous 
contractions. These results suggest the spontaneous contractions of ACR-
12(V/S) arise from the activity of a previously characterized ACR-2R and not the 
presence of an aberrant nAChR.   
One might expect the spontaneous contractions to arise out of 
deregulated timing mechanisms in the circuit. Interference with the timed 
activation of cholinergic neurons, which drive the locomotory circuit, could be 
sufficient for generating locomotory phenotypes. However, animals expressing 
ACR-12(V/S) in cholinergic motor neurons along the dorsal side with a cell 
specific promoter did not exhibit spontaneous contractions. This suggests the 
bilateral excitation of body wall musculature from ACR-12(V/S) in all cholinergic 
motor neurons is required for spontaneous contractions. Furthermore, these 
animals did not exhibit any profound changes in locomotory movement. One 
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reason for this could be the presence of the acr-12(ok367) mutant background. 
Previous behavior analysis has revealed acr-12 mutants have reduced body 
bends/minute compared to wild type and an inconsistent waveform (Chapter II). 
This mutant background could be masking subtle changes in movement as a 
function of ACR-12(V/S) expression in DA and DB motor neurons. Nervous 
system development is not obviously affected by the expression of ACR-12(V/S) 
and increased aldicarb hypersensitivity suggests these animals have increased 
ACh release. Transgenic ACR-12(V/S) animals have provided insights into the 
diverse roles of cholinergic signaling in the C. elegans locomotory circuit. In the 
future we will be able to address additional questions about subunit composition, 
localization, and alternative degrees of excitability. 
As previously mentioned in the introductory chapter of this thesis the 
activity of the locomotory circuit starts with command interneurons and is 
executed through excitatory and inhibitory motor neurons. Sensory information is 
relayed through command interneurons that synapse onto excitatory motor 
neurons. These excitatory motor neurons form dyadic synapses with body wall 
muscle and inhibitory GABA motor neurons(White et al., 1986). There are 5 sets 
of command interneurons: AVA, AVD, and AVE, for regulating backwards 
movement and AVB and PVC which regulate forward movement. The AVA, AVE, 
and AVD initiate backward movement through electrical and chemical contacts 
with the A motor neurons (backwards movement). AVB and PVC regulate 
forward movement via gap junctions and chemical synapses with B type motor 
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neurons (forward movement) (Chalfie et al., 1985; Wicks et al., 1996; Zheng et 
al., 1999). Specifically, AVA and AVB are directly connected with their respective 
motor neuron populations through gap junctions and function to drive forward 
and backward directionality of the animal. Animals mutant for innexins, UNC-7 
and UNC-9, shortened body bends, or kinking, which arise from equal activation 
of both forward and backward motor neurons. Interestingly, experiments where 
the activity of either motor neuron population was reduced, the animals resumed 
movement biased by the shift in the activity equilibrium (Kawano et al., 2011).  
One model for the diverse roles of ACR-12R* in cholinergic and 
GABAergic neurons would be support maintaining the activity equilibrium of the 
motor neurons. For example, during forward movement spill over of ACh from the 
synapses of B motor neurons activate ACR-2* receptors on the dendrites of B 
motor neurons. Activation of these receptors maintains a higher activity level in B 
motor neurons than that of A motor neurons and therefore maintains forward 
movement. Animals expressing the light activated ion channel, channelrhodopsin 
(ChR-2), in both A and B motor neurons exhibited a dramatic decrease in 
movement and ability to propogate a wave with blue light exposure. This further 
supports the idea that changes in this equilibrium will result in changes in 
directionality of the animal (Kawano et al., 2011). To address this one experiment 
would be to express ACR-12(V/S) using cell specific promoters in A or B motor 
neurons in order to hyperactivate specific classes of neurons in innexin mutants 
and look for a restoration in either directionality of movement. Further down the 
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neuronal circuit is the timed activation of GABA neurons and body wall muscle. 
We have identified a unique class of ACR-12R* that play a role in maintaining the 
coordination of body bends. Loss of these receptors leads to variability in long 
forward runs (Chapter II). Taken together these results suggest mechanisms 
dedicated to coupling each level of the locomotory circuit are important for the 
overall propagation of the sinusoidal wave. Interestingly, we found that loss of 
ACR-12R* in GABA motor neurons ameliorated the paralysis induced by the 
expression of ChR-2 in cholinergic motor neurons. The animals were able to 
move forward exhibiting only mild effects from blue light exposure. The presence 
of forward movement suggests that ACR-12R* in GABA motor neurons alters the 
motor circuit equilibrium to favor forward movement. One possibility is that a 
decrease in synaptic drive from photoresponsive ACh MNs allows for 
coordination of GABA MN activity through other pathways, enabling movement.  
The many roles of nAChRs in nematode movement provides an 
opportunity to address additional questions surrounding cholinergic signaling that 
will be beneficial for our understanding of vertebrate CNS function. Are there 
changes in downstream NMJ receptor localization when cholinergic motor 
neurons are hyperactive? Are there obvious changes in behavior in a more 
challenging environment for movement? For example, in swimming behaviors do 
transgenic ACR-12(V/S) animals exhibit changes in body wall muscles due to 
over activation. Mutations to alternative amino acids have less profound effects in 
channel kinetics, using these mutations we can potentially identify alternative 
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phenotypes associated with a more mild increase in signaling (Imoto et al., 1988; 
Revah et al., 1991). For example, it would be interesting to see if alternative, less 
severe mutations in the second transmembrane domain of ACR-12 could affect 
the generation of spontaneous contractions.  
Characterizing preferential neuronal degeneration—mechanisms of toxicity for 
GABA neurons 
Unexpectedly, we found cell specific expression of ACR-12(V/S) in GABA 
neurons produced toxicity and subsequent loss of GABA neurons. The 
cholinergic nervous system remained intact with no obvious changes in 
connectivity, while the GABA nervous system exhibit neuronal degeneration that 
was severe in most animals. Toxicity was cell autonomous, suggesting 
fundamental differences in motor neuron populations. This finding could provide 
valuable insights into unique properties of GABA neurons. Perhaps GABA 
neurons express specific protein(s) that makes GABA neurons more sensitive to 
changes in activity. Alternatively, these neurons may lack a protein protective of 
toxicity. This toxicity was variable across animals and could be observed as early 
as L1 animals. The variability in degeneration may arise from specific activity 
requirements of subsets of neurons. Perhaps the more heavily active neurons 
during development are more susceptible to toxicity while other neurons with less 
activity demands are able to compensate for excess signaling. It will be 
interesting to see if the GABA neurons that are degenerating are of a specific 
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class, VD or DD. During the transition from the first larval stage to the second 
larval stage (L2) the number of ventral nerve cord motor neurons increases 
substantially, with the addition of >50 motor neuron cell bodies (Sulston and 
Horvitz, 1977). In the future we can identify the additional subunits of this 
receptor by looking for suppression of degeneration. Additionally, genetic 
screens could identify the mechanisms of degeneration or proteins important for 
the synthesis of nAChRs. The loss of GABA neurons has surprising effects on 
the postsynaptic receptors. 
Despite dramatic defects in GABA motor neuron innervation of the dorsal 
musculature, we found the UNC-49 receptor remained localized to discrete sites 
along the dorsal cord. One might expect in the absences of presynaptic motor 
neurons there would be consequences for the downstream inhibitory receptors of 
the NMJ. One possibility is that the internalization or delocalization of receptors 
requires more time. While we observe defects as early as the L1 stage, we 
cannot be sure that degeneration does not also occur in later life stages. 
Therefore, at this time we cannot say the presynaptic neuron has been 
degenerated for a pre-determined amount of time. It is possible the gaps in 
coverage in the dorsal cord we see are from recent loss of presynaptic neurons. 
Another possibility is once the NMJ has formed the proper localization of the 
excitatory NMJ receptors, ACR-16 and UNC-29, aid in maintaining UNC-49 
localization. In the future it will be interesting to examine the localization of UNC-
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49 receptors under conditions where we can track degeneration of presynaptic 
GABA neurons.  
One might then expect these animals to exhibit phenotypes similar to the 
phenotypes of GABA deficient mutants. Similar to GABA deficit mutants GABA 
specific expression of ACR-12(V/S) resulted in aldicarb hypersensitivity (data not 
shown) and reduced movement. However, these transgenic animals exhibited a 
low occurrence of the classical shrinker phenotype associated with GABA deficit 
mutants such as unc-49(e382) (Bamber et al., 1999). One possibility is that the 
remaining GABA neurons expressing sensitized ACR-12(V/S) are enough to 
compensate for the increased excitation in the locomotory circuit. Another 
possibility is the sensitized ACR-12(V/S) receptor actually inhibits GABA neuron 
activity but the neurons still have residual tonic activity. In this case, using the 
previously mentioned method of alternative second transmembrane domain 
mutations we may be able to examine behaviors associated with mild increases 
in GABA neuronal activity.  
In conclusion, identification of a distinct class of nAChRs in driving the 
activation of subsets of motor neurons during nematode locomotion has provided 
us with insights into the mechanisms of vertebrate CNS functions. nAChRs can 
have dramatically different roles in regulating the activity of neuronal circuits 
depending on the amount of neurotransmitter present. ACR-12 mutants in low 
levels of ACh release were unable to maintain consistent amplitude across 
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consecutive body bends, while these mutants were able to suppress paralysis 
induced by elevated levels of ACh release induced by Channelrhodopsin-2. 
Interfering with the timed activation of cholinergic motor neurons activating the 
dorsal body muscle was not sufficient to generate spontaneous contraction. 
However, simultaneous activation of all the cholinergic motor neurons is sufficient 
for spontaneous contractions. In the process of this thesis work we have 
obtained several tools to examine new questions of subunit composition, 
localizations and mechanisms of activity. Moving forward we will also be able to 
characterize factors mediating the unique toxicity tolerance of GABA neurons 
compared to their cholinergic motor neurons counterparts. Additionally, it will be 
interesting to identify the mechanisms maintaining the inhibitory NMJ regulation, 
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Inappropriate or excessive activation of ionotropic receptors can have 
dramatic consequences for neuronal function and, in many instances, leads to 
cell death. In Caenorhabditis elegans, nicotinic acetylcholine receptor (nAChR) 
subunits are highly expressed in a neural circuit that controls movement. Here, 
we show that heteromeric nAChRs containing the acr-2 subunit are diffusely 
localized in the processes of excitatory motor neurons and act to modulate motor 
neuron activity. Excessive signaling through these receptors leads to cell-
autonomous degeneration of cholinergic motor neurons and paralysis. C. 
elegans double mutants lacking calreticulin and calnexin—two genes previously 
implicated in the cellular events leading to necrotic-like cell death (Xu et al., 
2001)—are resistant to nAChR mediated toxicity and possess normal numbers of 
motor neuron cell bodies. Nonetheless, excess nAChR activation leads to 
progressive destabilization of the motor neuron processes and, ultimately, 
paralysis in these animals. Our results provide new evidence that chronic 
activation of ionotropic receptors can have devastating degenerative effects in 
neurons and reveal that ion channel-mediated toxicity may have distinct 
consequences in neuronal cell bodies and processes. 
 
Introduction 
Roles for ionotropic receptor-mediated signaling in the nervous system 
extend far beyond a well characterized participation in cell– cell communication 
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at synapses. Ionotropic receptor activation is one of several key factors that 
influence cell survival in developing and mature nervous systems. For example, 
signaling through nicotinic acetylcholine receptors (nAChRs) promotes the 
elimination of neurons in the developing avian autonomic nervous system 
(Hruska et al., 2009; Hruska and Nishi, 2007), and inappropriate pharmacological 
activation of nAChRs in the Caenorhabditis elegans nervous system leads to 
developmental arrest (Ruaud and Bessereau, 2006). In the mature nervous 
system, inappropriate or excessive ion channel activation can have dramatic 
consequences. In mammals, hypoxic events, such as stroke, lead to excitotoxic 
cell death as a consequence of excess glutamate release and hyperexcitation of 
ionotropic glutamate receptors (iGluRs) (Sattler and Tymianski, 2001). Likewise, 
mutations that cause prolonged activation of nAChRs or iGluRs can lead to 
neurodegeneration and cell death in organisms ranging from nematodes to 
mammals (Heintz and Zoghbi, 2000; Labarca et al., 2001; Miwa et al., 2006; Orb 
et al., 2004; Orr-Urtreger et al., 2000; Treinin and Chalfie, 1995; Zuo et al., 
1997). Excess ion channel activation is also a contributing factor in 
neurodegenerative diseases. For example, the selective vulnerability of motor 
neurons to cell death in amyotrophic lateral sclerosis (ALS) is believed to arise, 
at least in part, from hyperactivation of calcium-permeable AMPA type iGluRs 
(Grosskreutz et al., 2010; Kwak and Weiss, 2006). Interestingly, in various 
mouse models of motor neuron diseases, including ALS, genetic manipulations 
that prevent the death of motor neuron cell bodies are not successful in halting 
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disease progression (Gould et al., 2006; Sagot et al., 1995). This result implies 
that ion channel hyperactivation may contribute to degenerative events that 
persist even under conditions when neuronal cell death is attenuated. Shared 
features of ion channel-mediated degeneration across these diverse receptor 
types and systems suggest that aspects of this process may be broadly 
conserved across organisms (Driscoll and Gerstbrein, 2003). In most cases, 
however, a cohesive picture of the cellular events that influence the progression 
toward cell death as a consequence of ion channel hyperactivation remains 
unclear. 
Ionotropic receptor signaling and its contribution to neurodegeneration can 
be dissected in detail in the compact nervous system of the nematode 
Caenorhabditis elegans. Here, we provide evidence that the non-α nAChR 
subunit ACR-2 contributes to a heteromeric receptor that is important for 
regulating the activity of excitatory motor neurons. A pore modification in ACR-2 
leads to loss of motor neurons and paralysis of the animal. Genetic ablation of 
nAChR subunits that coassemble into a heteromeric receptor complex with ACR-
2 suppresses ACR-2(L/S) (where L/S is leucine-to serine substitution) toxicity. In 
addition, C. elegans double mutants lacking two genes previously implicated in 
calcium homeostasis and necrotic cell death (crt-1/calreticulin and cnx-
1/calnexin) are resistant to nAChR-mediated toxicity and possess normal 
numbers of motor neuron cell bodies. Nonetheless, we observe a progressive 
degeneration of the motor neuron processes that leads to paralysis in these 
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animals. Thus, ion channel hyperactivation has distinct consequences for 
neuronal cell bodies and processes. 
Materials and Methods 
Molecular biology 
AChR subunit constructs. The full-length ACR-2::GFP transgene 
(pDM1232) was generated by introducing the green fluorescent protein (GFP) 
coding sequence in-frame into the sequence of an acr-2 genomic fragment (-
3353 to +7776 bp relative to the translational start site) encoding the  intracellular 
loop between transmembrane domains TM3 and TM4. The full-length ACR-
2(L/S) construct (pBB9) was generated by PCR-based site directed mutagenesis 
using mutant primers and pDM1232 as the template. The Pacr-2::ACR-12 cDNA 
(pHP3) and Punc-47::ACR-12 cDNA (pBB25) constructs were generated by 
amplifying the acr-12 cDNA from the expressed sequence tag yk1093d12 (gift 
from Yuji Kohara, National Institute of Genetics, Mishima, Japan) using 
sequence-specific primers designed to the start and stop codons of acr-12 and 
subcloning it into the NheI/SacI sites of a plasmid containing an ~3.3 kb promoter 
for the acr-2 gene or into a plasmid containing a 1.3 kb promoter for the unc-47 
gene. 
Transcriptional reporters. The Punc-47::mCherry construct (pPRB5) was 
generated by subcloning an AgeI/AatII fragment that contained the full-length 
mCherry coding sequence into a vector containing a 1.3 kb promoter for the unc-
47 gene. The Pacr-2::GFP (pPRB19) construct was generated by subcloning an 
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AatII/BamHI fragment that contained an ~3.3 kb promoter for the acr-2 gene into 
a vector containing the GFP coding sequence. 
C. elegans strains 
C. elegans strains were grown on nematode growth medium (NGM) plates 
with the OP50 strain of Escherichia coli at 22°C using standard laboratory 
procedures. Wild-type animals are the N2 Bristol strain. All transgenic strains 
were obtained by microinjection of plasmid DNA into the germ line and data 
presented are from a single representative transgenic line unless noted 
otherwise. In all cases, lin-15(n765ts) mutants were injected with the lin-15 
rescuing plasmid (pL15EK; 30 ng/μl) and one or more of the following plasmids 
(30 ng/μl): pBB9, pBB25, pDM1232, pHP3, pPRB4, pPRB5, pPRB14, pPRB19. 
Multiple independent extragenic lines were obtained for each transgenic strain. 
Stably integrated lines were generated as necessary by x-ray integration and 
outcrossed at least four times to wild type. The transgenic strain expressing the 
integrated ACR-2(L/S) transgene (ufIs25) was outcrossed 10 times to wild type.  
The following strains were used in this study: RB1559 acr-2(ok1887 ), 
IZ421 acr-12(ok367 ), RB2071 ced-3(ok2734 ), VC1801 cnx-1(ok2234 ), RB1021 
crt-1(ok948), IZ74 unc-29(x29), CB904 unc-38(e264), CB306 unc-50(e306), 
VC731 unc-63(ok1075), CB883 unc-74(e883), IZ380 ufIs31, IZ814 ufIs25, IZ625 
ufIs25;ufIs31, IZ790 ufIs49, IZ627 ufIs42, LX949 vsIs48, IZ924 ufIs25;vsIs48, 
IZ950 ced-3(ok2734); ufIs25;vsIs48, IZ877 cnx-1(ok2234);ufIs25;vsIs48, IZ926 
crt-1(ok948); ufIs25;vsIs48, IZ976 crt-1(ok948);cnx-1(ok2234 );ufIs25;vsIs48, 
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IZ971 crt-1(ok948);cnx-1(ok2234);vsIs48, IZ927 crt-1(ok948);cnx-1(ok2234); 
ufIs42, IZ787 unc-29(x29);ufIs25, IZ928 acr-3(ok2049);ufIs265, IZ929 acr-
5(ok180);ufIs25, IZ930 acr-9(ok933);ufIs25, IZ931 acr-19(ok967); ufIs25, IZ932 
acr-23(ok2840);ufIs25,IZ446 unc-38(e264);ufIs25, IZ659 unc-50(e306);ufIs25, 
IZ921 unc-63(ok1075);ufIs25, IZ490 unc-68(e540); ufIs25, IZ604 unc-
74(e883);ufIs25, IZ673 acr-12(ok367 );ufIs25;ufEx148, IZ937 acr-
12(ok367);ufIs25;ufIs60, IZ861 acr-12(ok367);ufIs25;ufEx191. 
Genetic screen and identification of suppressors of 
ACR-2(L/S)-induced paralysis 
Paralyzed animals expressing the integrated ACR-2(L/S) array (ufIs25) 
were mutagenized with 50 mM ethyl methanesulfonate (Brenner, 1974). Young 
adult F2 progeny of ~20,000 mutagenized animals were washed twice with M9 
buffer and transferred to fresh plates. After allowing time for the animals to 
disperse, moving animals were picked to single plates. Eighty one candidate 
suppressors were isolated. A secondary screen showed that fifty-one of these 
were resistant to the paralyzing effects of levamisole. For genetic 
complementation tests, males carrying a mutation in candidate levamisole-
resistance genes were crossed with hermaphrodites carrying the ACR-2(L/S) 
transgene and a suppressor mutation. F1 progeny were scored for paralysis. A 
cross was performed in parallel using N2 males to identify X-linked suppressor 
mutations and determine dominance recessivity. The mapping of acr-12 alleles 
was performed in the presence of the ACR-2(L/S) transgene. A strain carrying 
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the integrated ACR-2(L/S) transgene (ufIs25) on linkage group I was 
backcrossed 7X to the CB4856 Hawaiian strain. acr-12 alleles were mapped to a 
region the right of +8 on the X chromosome using the SNP mapping procedure 
as described previously (Davis et al., 2005; Wicks et al., 2001). 
Behavioral assays 
All behavioral analysis was performed with young adult animals (24 h post-L4) at 
room temperature (22°C–24°C); different genotypes were scored in parallel, with 
the researcher blinded to the genotype. 
Aldicarb and levamisole assays. Staged populations of adult animals 
(~10) were transferred to NGM plates containing 1mM aldicarb (Chem- 
Service), and movement was assessed every 15 min for 2 h. Data represent 
the mean ±SEM of at least four assays. For levamisole assays, staged 
populations of adult animals were scored for paralysis after 120 min on plates 
containing 200 μM levamisole. 
Body bend analysis. Body bends were scored on unseeded NGM agar. 
Animals were transferred from their culture plate to an unseeded plate and 
allowed to crawl away from any food that might have been transferred. The 
animals were then gently transferred without food to another unseeded plate and 
allowed to recover for 1 min. After the recovery period, the animals were filmed 





Confocal microscopy was performed using a Zeiss Axioskop 2 microscope 
system and LSM Pascal 5 imaging software (Zeiss). Images were processed 
using ImageJ software (open source). Epifluorescent imaging was performed 
using a Zeiss Axioimager M1 microscope and Axiovision software (Zeiss). 
Movies and still images for behavioral analyses were obtained using an Olympus 
SZ61 upright microscope equipped with a FireWire camera (ImagingSource). For 
the developmental timeline, synchronized populations were obtained by 
bleaching gravid animals on NGM plates seeded with OP50. The resulting 
progeny were allowed to mature at room temperature. Animals were imaged at 
16, 28, 38, and 48 h after bleaching using wide-field epifluorescent microscopy, 
and the number of surviving cell bodies were counted manually with the 
researcher blinded to genotype. 
Results 
acr-2 encodes a nicotinic receptor subunit expressed in cholinergic motor 
neurons 
The C. elegans genome encodes 29 nAChR subunits that contribute to 
the formation of distinct classes of homopentameric and heteropentameric 
receptors (Jones et al., 2007; Rand, 2007). Two classes of nAChRs formed from 
six of these subunits are expressed in body wall muscle cells and required for 
neuromuscular signaling (Francis et al., 2005; Richmond and Jorgensen, 1999; 
Touroutine et al., 2005). Previous studies have suggested that the expression of 
several nicotinic acetylcholine receptor subunits, including the non-α subunit acr-
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2, is enriched in motor neurons of the ventral nerve cord (Cinar et al., 2005; 
Hallam et al., 2000; Jospin et al., 2009). To determine which ventral cord motor 
neurons express acr-2, we examined transgenic strains that expressed GFP 
(Chalfie et al., 1994) under the control of acr-2 regulatory sequences. Expression 
of Pacr-2::GFP was limited to the nervous system and largely restricted to 
neurons located in the ventral nerve cord. Expression of Pacr-2::GFP did not 
overlap with expression of a GABAergic mCherry reporter (Punc-47::mCherry), 
indicating that expression of acr-2 was limited to cholinergic motor neurons (DA, 
VA, DB, VB) in the ventral nerve cord of adult animals (Figure A1-1A). To 
determine the subcellular localization of ACR-2, we generated transgenic strains 
that expressed a full length ACR-2::GFP fusion protein in which GFP was 
inserted in frame in the intracellular loop region located between transmembrane 
domains three and four (Figure A1-S1, available at www.jneurosci.org as 
Supplemental Material). Expression of the GFP reporter construct could be 
observed at all larval stages and in the adult. We noted the onset of expression 
in late embryogenesis by the threefold stage (~550 min after fertilization). In first 
larval stage (L1) animals, when DA and DB motor neurons are the sole excitatory 
motor neurons present, ACR-2 expression was clearly visible in ventral nerve 
cord processes. DA and DB motor neuron dendrites receive synaptic input in the 
ventral cord, and these neurons extend commissural axons to the dorsal cord 
where they form neuromuscular synapses with the dorsal musculature. In adult 
animals, we found that the fusion protein was diffusely localized to neuronal 
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processes of the dorsal and ventral nerve cords. Our analysis suggests that 
ACR-2 is diffusely localized with enriched expression in the dendritic 
compartment of cholinergic motor neurons. The locomotory control interneurons 
provide synaptic input to the excitatory motor neurons; however, the role of 
acetylcholine (ACh) in this signaling remains unclear. To evaluate whether the 
locomotory control interneurons are cholinergic, we examined transgenic strains 
that coexpressed GFP under control of regulatory elements for the gene 
encoding the ACh vesicular transporter (Punc-17::GFP) together with the red 
fluorescent protein mCherry expressed under the control of the regulatory 
elements for the nmr-1 gene (Pnmr-1::mCherry) (Figure A1-S2). nmr-1 is 
expressed in the AVA, AVD, AVE ,and PVC locomotory control interneurons, as 
well as the RIM and AVG neurons (Brockie et al., 2001). We noted no overlap in 
the pattern of the red and green fluorescent signals with the possible exception of 
the interneuron AVE, indicating that these two reporters labeled almost 
completely independent cell populations. These data are consistent with the idea 
that the locomotory control interneurons are not primarily cholinergic. The 
enriched expression of ACR-2 in the dendritic compartment of motor neurons 
may reflect the involvement of ACR-2 receptor complexes at synapses between 
AVE and cholinergic motor neurons; however, the lack of Punc-17::GFP 
expression in a majority of locomotory control interneurons and the diffuse 
distribution of ACR-2 are inconsistent with an exclusive role at synapses. 
acr-2 mutants have motor deficits  
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The cholinergic motor neurons in the ventral nerve cord make synaptic contacts 
onto the body wall musculature that drives nematode locomotion. To evaluate the 
contribution of ACR-2 to cholinergic motor neuron excitability and motor output, 
we obtained a strain carrying a deletion mutation (ok1887) in the acr-2 genomic 
locus. The acr-2(ok1887) eliminates ~2.8 kb of chromosomal DNA, including the 
transcriptional start, and is likely to be a null. Animals homozygous for the 
ok1887 allele are healthy and viable. acr-2(ok1887) mutants are not obviously 
uncoordinated, though closer inspection revealed a modest decrease in 
locomotion rate (Figure A1-1B). Expression of the full-length ACR-2::GFP fusion 
protein in acr-2(ok1887) mutants was sufficient to restore normal movement.  
The acetylcholinesterase inhibitor aldicarb has proven to be a useful tool 
for detecting alterations in neurotransmitter release from cholinergic motor 
neurons. To test whether ACR-2 receptor complexes may be important for 
regulating activity of the cholinergic motor neurons, we examined whether acr-2 
mutant worms exhibit altered sensitivity to the paralyzing effects of aldicarb. acr-2 
mutant animals were slightly resistant to paralysis by aldicarb, and this effect was 
normalized by expression of ACR-2::GFP (Figure A1-1C). These data are 
consistent with the notion that ACR-2 plays a role in modulating the activity of 
cholinergic motor neurons but suggest that ACR-2 is not absolutely required for 
motor neuron depolarization. 
Introducing a dominant mutation in ACR-2 leads to profound motor deficits  
124 
 
The second transmembrane domains of Cys-loop family ligand-gated ion 
channel subunits are well known to line the ion channel pore and play a critical 
role in channel gating. In particular, a highly conserved nonpolar residue 
(typically leucine) in the M2 region has been shown to have profound effects on 
receptor activation properties (Figure A1-S3). Substitution of a polar amino acid 
(e.g., serine) for the leucine at this position produces a gain-of-function effect, 
resulting in increased receptor activation and very slow inactivation (Labarca et 
al., 1995; Revah et al., 1991).  
We engineered the homologous leucine-to-serine point mutation into the 
sequence encoding the M2 9' position of an acr-2 rescuing construct to generate 
ACR-2(L/S) (Figure A1-S3). Transgenic animals expressing an integrated ACR-
2(L/S) array (ufIs25) were used for all subsequent analyses. These animals are 
viable and have roughly normal brood sizes; however, adult animals are smaller 
than their wild-type counterparts (Figure A1-2). Moreover, we noted obvious 
locomotory defects in transgenic ACR-2(L/S) animals (Figure A1-2C). These 
defects were present in all larval stages as well as adult animals. Transgenic 
ACR-2(L/S) animals generated almost tenfold fewer body bends than the wild 
type and failed to propagate the sinusoidal wave that is typical of nematode 
movement, although animals remained capable of head foraging movements. 
The effects of ACR-2(L/S) were dominant, consistent with the notion that the 
phenotypes arose as a consequence of expression of a gain-of-function receptor. 
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Our results suggest that motor output to head muscles is unaffected, while 
control of body wall musculature is dramatically impaired in these animals. 
ACR-2(L/S)-induced motor neuron degeneration  
Examination of the ventral nerve cord region of transgenic ACR- 2(L/S) 
animals by differential interference contrast (DIC) microscopy showed that a 
subset of the ventral nerve cord neurons that normally express acr-2 swelled 
beyond their normal diameter and eventually disappeared, presumably as a 
result of cell death (Figures A1-3, 4). These results suggest that enhanced 
cholinergic signaling mediated by receptors incorporating ACR-2(L/S) leads to 
motor neuron toxicity. To characterize this in more detail, we examined the 
effects of ACR-2(L/S) expression in strains carrying fluorescent reporters that 
label populations of cholinergic neurons. We observed only dim Pacr-2::GFP 
fluorescence in the ventral nerve cord of ACR-2(L/S) animals, suggesting that 
many of the neurons labeled by this reporter were lost (data not shown). To 
evaluate the specificity of this effect for neurons that expressed acr-2, we 
examined a Punc-17::GFP reporter that is expressed in all cholinergic neurons 
(Figure A1-3) (Chase et al., 2004). While ACR-2(L/S) expression did not produce 
obvious differences in the number of head neurons labeled by Punc-17::GFP, we 
observed a dramatic decrease in the number of ventral nerve cord motor neuron 
cell bodies; yet, several motor neuron cell bodies remained present. The 
surviving neurons included the six VC motor neurons that do not normally 
express acr-2 and a more variable group of 10–12 additional excitatory motor 
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neuron cell bodies (Figures A1-3; Figure A1-S4). Based on the position and 
number of cell bodies and commissural processes, the additional surviving 
neurons included both DA and DB motor neurons that normally express acr-2, as 
well as AS motor neurons that do not. Similar to our observations for ACR-
2(L/S)-induced paralysis, the effects of ACR-2(L/S) on motor neurons were 
dominant. To evaluate the effects of ACR-2(L/S) on GABA motor neurons, we 
coexpressed ACR-2(L/S) together with a mCherry transcriptional reporter that 
labeled GABA neurons (Punc-47::mCherry) (Figure A1-3C,D). We observed that 
the full complement of GABA neurons was present and morphologically normal. 
These data suggest that ACR- 2(L/S) acts cell autonomously to promote 
degeneration of motor neurons and that specific neurons are differentially 
susceptible to the effects of ACR-2(L/S) expression. 
Motor neuron loss occurs soon after onset of ACR-2(L/S) expression  
As noted above, we observed clear ACR-2::GFP fluorescence in late 
embryogenesis. We found that threefold embryos coexpressing ACR-2(L/S) with 
the Pacr-2::GFP transcriptional reporter possessed normal numbers of GFP-
positive neurons, suggesting that ACR-2(L/S) toxicity occurred after hatch 
(Figures A1-S4). To precisely determine the onset of motor neuron cell death, we 
imaged transgenic ACR-2(L/S) animals that coexpressed the Punc-17::GFP 
transcriptional reporter at various time points ranging from newly hatched larvae 
to adults (Figure A1-4). We observed significant motor neuron loss in newly 
hatched larvae. Roughly 40% of the 16 cholinergic motor neurons present in L1 
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animals were lost within 16 h after hatch. During the transition from the first larval 
stage to the second larval stage (L2) the number of ventral nerve cord motor 
neurons increases substantially, with the addition of >50 motor neuron cell 
bodies (Sulston and Horvitz, 1977). In transgenic ACR-2(L/S) animals we 
observed only a slight increase in the number of cell bodies labeled by Punc-
17::GFP over the course of development. Even by the time transgenic ACR-
2(L/S) animals had clearly reached adulthood, the number of Punc-17::GFP 
labeled motor neuron cell bodies was roughly comparable to that of a wild-type 
L1 animal. The VC motor neurons do not express acr-2 and are clearly present in 
transgenic ACR-2(L/S) animals (Figure A1-3; Figure A1-S5). Therefore, the small 
developmental increase in the number of motor neuron cell bodies that we 
observe in transgenic ACR-2(L/S) animals likely represents the postembryonic 
addition of VC neurons. These results suggest that the other classes of motor 
neurons that are born postembryonically and normally express acr-2 (e.g., VA, 
VB) are almost completely absent in adult transgenic ACR-2(L/S) animals.  
Mutations that suppress paralysis define the subunits of a neuronal nAChR  
To identify genes required for the toxic effects of transgenic ACR-2(L/S) 
expression, we conducted a forward genetic screen for suppressors of ACR-
2(L/S)-induced paralysis. We screened the F2 progeny of mutagenized 
hermaphrodites that expressed ACR-2(L/S) and selected animals that exhibited 
improved movement. A close examination of the mutants isolated from the 
screen showed that two phenotypic classes were easily distinguishable. One 
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class of animals phenocopied strains that lack a well characterized heteromeric 
nAChR that mediates excitatory signaling at the neuromuscular junction (NMJ) 
and is a principal target of the antihelminthic drug levamisole (L-AChR). We 
found that members of this class were strongly levamisole-resistant, and we 
isolated alleles of the levamisole resistance genes unc-38, unc-63, unc-74, and 
unc-50 from these animals (Supplemental Table A1-S1). We also crossed 
available strains carrying single loss-of-function mutations in known levamisole 
resistance genes with transgenic ACR-2(L/S) animals (Table A1-1). Consistent 
with the results from our forward genetic approach, loss-of-function mutations in 
either unc-38, unc-63, unc-74, or unc-50 were sufficient to suppress ACR-2(L/S) 
toxicity and restore movement (Figure A1-5A). Interestingly, we also found that 
unc-29, a non-α subunit required for L-AChR function, was not required for ACR-
2(L/S)-induced paralysis. Likewise, acr-16, an essential subunit of homomeric 
nAChRs at the NMJ, was not required for ACR-2(L/S)-induced paralysis. unc-38 
and unc-63 encode nAChR α subunits that are required for L-AChR function at 
the NMJ but are also expressed in the nervous system (Culetto et al., 2004; 
Eimer et al., 2007; Fleming et al., 1997). unc-50 and unc-74 encode genes 
previously implicated in L-AChR maturation and are broadly expressed in 
muscles and neurons. Our analysis suggests that each of these gene products 
may contribute in a cooperative fashion to the generation of functional ACR-
2(L/S) receptors and subsequent toxicity.  
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A smaller number of animals isolated from the screen exhibited 
uncoordinated movement with deep body bends and showed normal sensitivity 
to the paralyzing effects of levamisole. We determined that the suppressor 
mutations in this second phenotypic class represented one complementation 
group and were X linked. Using single-nucleotide polymorphism mapping, we 
mapped one allele to the right of +8 on the X chromosome. The nAChR subunit 
gene acr-12 is located in this genomic region. Sequence analysis revealed four 
nonsense mutations and two missense mutations in the acr-12 coding sequence 
among our second class of suppressors (Figure A1-5B). We also found that a 
deletion mutation (ok367) in the acr-12 gene suppressed paralysis in transgenic 
ACR- 2(L/S) animals and prevented the loss of motor neuron cell bodies. 
Expression of a full-length acr-12 rescuing construct in acr-12(ok367);ACR-
2(L/S) animals restored paralysis, verifying that acr-12 is required (Figure A1-
5C,F). In contrast, we found that several other nAChR subunits with restricted 
expression to the nervous system were not required for ACR-2(L/S)- induced 
paralysis (Table A1-1). acr-12 encodes a nicotinic receptor α subunit that is 
broadly expressed in the nervous system, including many ventral cord motor 
neurons, but is not expressed in body wall muscles (Cinar et al. 2005; Gottschalk 
et al. 2005). acr-12(ok367) mutants have grossly normal movement and show 
normal sensitivity to the paralyzing effects of levamisole. To test whether acr-12 
expression solely in cholinergic motor neurons is sufficient for ACR-2(L/S)-
induced toxicity, we specifically restored expression of acr-12 to either ACh or 
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GABA motor neurons of acr-12(ok367) mutants that carried the ACR-2(L/S) 
transgene (Figure A1-5C– H). We found that-specific expression of the acr-12 
cDNA in cholinergic motor neurons of transgenic acr-12(ok367); ACR-2(L/S) 
mutants led to ACR-2(L/S) toxicity and paralysis. In contrast, specific expression 
in GABA neurons had no effect. Our results indicate that acr-12 expression in 
cholinergic motor neurons is specifically required for ACR-2(L/S)-induced cell 
death. Furthermore, our results suggest that coassembly of ACR-2(L/S) into a 
heteromeric receptor complex with UNC-38, UNC-63, and ACR-12 is required to 
produce toxicity.  
ACR-2(L/S)-induced motor neuron loss is suppressed in cnx-1;crt-1 double 
mutants 
 At least two mechanistically distinct types of cell death have been 
described. Programmed cell death or apoptosis is a form of cell death common in 
development and tissue homeostasis and occurs by a genetic program that is 
broadly conserved across metazoans (Danial and Korsmeyer, 2004). Necrosis 
generally occurs following cellular injury and is often characterized by swelling of 
the dying cell (Festjens et al., 2006; Golstein and Kroemer, 2007). Our forward 
genetic screen did not identify genes previously implicated in the execution of 
either of these forms of cell death. To determine how ACR-2(L/S) expression 
leads to cell death, we introduced the ACR-2(L/S) transgene into genetic 
backgrounds deficient for genes essential for either apoptotic cell death or 
necrotic cell death (Figure A1-6). We found that a loss-of-function mutation in 
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proapoptotic ced-3 (Ellis and Horvitz, 1986) or a gain-of-function mutation in anti-
apoptotic ced-9 (Hengartner et al., 1992) had no effect on ACR-2(L/S)-induced 
deaths. Thus, the programmed cell death machinery is not required for ACR-
2(L/S)-induced neurodegeneration.  
Dysregulation of intracellular calcium levels contributes to cell death 
under a variety of circumstances, including necrotic cell death (Mattson et al., 
2000; Rao et al., 2004; Szydlowska and Tymianski, 2010). Calreticulin/CRT-1 
and calnexin/CNX-1 are endoplasmic reticulum (ER) resident proteins that serve 
dual functions as Ca2+ binding proteins and molecular chaperones that facilitate 
glycoprotein folding (Ellgaard and Frickel, 2003). In mice, loss of either calnexin 
or calreticulin produces severe phenotypes: calnexin knock-out mice die within 4 
months of birth, while knock-out of calreticulin results in embryonic lethality 
caused by defects in heart development (Denzel et al., 2002; Mesaeli et al., 
1999). In C. elegans, crt-1 and cnx-1 single mutants are viable, and loss-of-
function mutation in the crt-1 gene or RNA interference knockdown of cnx-1 
expression suppresses several cases of ion channel mediated cell death (Xu et 
al., 2001). We found that the deletion mutation cnx-1(ok2234) had no significant 
effect on ACR-2(L/S)-induced cell death, whereas the deletion mutation crt-
1(ok948) partially suppressed the loss of motor neurons observed in transgenic 




As calnexin and calreticulin perform similar cellular functions, we generated a 
strain carrying loss-of-function mutations in both genes to test whether they may 
act redundantly in ACR- 2(L/S)-induced toxicity. cnx-1;crt-1 double mutants were 
viable although smaller in size than wild-type animals, had grossly normal 
movement, and did not show obvious defects in nervous system connectivity.  
While ACR-2(L/S) expression in wild-type animals or cnx-1 and crt-1 single  
mutants caused paralysis across all developmental stages, we found that first 
larval stage cnx-1; crt-1 double mutants expressing ACR-2(L/S) were often 
capable of grossly normal locomotion (Figure A1-7A,B,H). We also observed that 
the full complement of 16 cholinergic motor neuron cell bodies was present in L1 
cnx-1;crt-1;ACR-2(L/S) animals, and we did not detect obvious defects in the 
connectivity of the cholinergic motor neurons (Figure A1-7C). These results 
indicate that embryonic born motor neurons developed normally and made 
appropriate synaptic contacts onto their partner muscle cells, suggesting that the 
combined loss of crt-1 and cnx-1 is strongly neuroprotective against ACR-2(L/S) 
toxicity in L1 animals. We observed that adult cnx-1;crt-1 double mutants 
expressing ACR-2(L/S) also possessed normal numbers of cholinergic motor 
neuron cell bodies, providing additional evidence that the presence of either 
calnexin or calreticulin is required for the cellular events that lead to ACR-2(L/S)- 
induced cell deaths (Figures A1-6F,G, 7D). However, larvae that had progressed 
beyond L1 and adult cnx-1;crt-1;ACR-2(L/S) animals were unable to propagate 
sinusoidal body bends and move effectively. This observation suggested that 
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ACR-2(L/S) expression in cnx-1;crt-1 double mutants led to a progressive 
disruption of motor function even when motor neuron death was attenuated.  
To determine whether altered motor neuron connectivity may underlie the 
paralysis of adult cnx-1;crt-1;ACR-2(L/S) animals, we made a close examination 
of the cholinergic motor neuron processes (Figure A1-7E–G,I). We found that 
defects in the motor neuron processes of control cnx-1;crt-1 double mutants 
occurred only rarely (Figure A1-S6), and these animals exhibited grossly normal 
movement across all stages of development. In cnx-1;crt-1 double mutants that 
expressed ACR-2(L/S), we observed defasciculation of the ventral nerve cord 
neuronal processes (in 96% of animals scored; n=30), as well as defects in the 
morphology of commissural axons (in 75% of axons) (Figure A1-7). We often 
observed several classes of defects within individual animals and, in some 
instances, individual commissural axons contained multiple defects. The defects 
were of several types. First, we observed abnormal axon branches that often 
terminated in growth cone like structures (54% of animals). Second, we observed 
ectopic sprouting with no clear single axonal process present (71% of animals). 
Finally, we observed axons with abnormal trajectories and wandering growth 
(83% of animals). These results suggest that the muscle targets of cholinergic 
motor neuron processes are not appropriately innervated in adult animals. We 
observed that the frequency of these defects increased dramatically after the first 
larval stage (Figure A1-7I), suggesting that a progressive deficiency in the 
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stabilization or maintenance of appropriate neuromuscular connectivity underlies 
the paralysis we observed in mature animals. 
 To better understand the mechanisms underlying the suppression of 
ACR-2(L/S)-mediated cell death in cnx-1;crt-1 animals, we directly evaluated the 
role of intracellular calcium. We found that culturing transgenic ACR-2(L/S) 
animals in the presence of dantrolene, an inhibitor of ER calcium release, or the 
calcium chelator EGTA (Figure A1-8A,B) led to a modest but significant increase 
in the number of surviving motor neuron cell bodies. Similarly, we observed 
reduced ACR-2(L/S) toxicity in unc-68 mutants lacking functional ryanodine 
receptors (Figure A1-8C). These results provide evidence that intracellular 
calcium signaling contributes to cell death in ACR-2(L/S) animals and support the 
idea that altered intracellular calcium in cnx-1;crt-1 double mutants may likewise 
contribute to the neuroprotection we observed. To test whether altered 
expression of ACR-2(L/S) in cnx-1;crt-1 double mutants may also be a 
contributing factor, we measured levels of ACR-2::GFP fluorescence. We 
observed an approximately twofold decrease in ACR-2::GFP fluorescence in 
both the cell bodies and ventral nerve cord of cnx-1;crt-1 double mutant animals 
compared to wild-type animals (Figure A1-8D–G). This result suggests that a 
decrease in the levels of ACR-2(L/S) in cnx-1;crt-1 animals also contributes to 




Our analysis of ACR-2-containing nicotinic receptors in C. elegans 
neurons has revealed common features between the function of these receptors 
in the C. elegans nervous system and roles for heteromeric nAChRs in the 
vertebrate brain (Dani and Bertrand, 2007). First, heteromeric nAChRs in the 
mammalian brain are not primarily concentrated at postsynaptic sites; instead, 
they are more variably localized to presynaptic, preterminal, and nonsynaptic 
sites. Similarly, we find that ACR-2-containing nAChRs appear diffusely localized 
to the processes of excitatory motor neurons, suggesting that these receptors 
may function at extrasynaptic sites. Second, heteromeric brain nAChRs primarily 
function to modulate neurotransmitter release and neuronal excitability. Our 
studies of acr-2 loss-of-function mutants indicate that heteromeric nAChRs 
containing ACR-2 modulate the excitability of cholinergic motor neurons but are 
not absolutely required for motor neuron depolarization or ACh release at 
neuromuscular synapses. Third, mouse studies have shown that knock-in 
expression of a heteromeric brain nAChR subunit bearing a L/S pore modification 
homologous to the one we describe here causes dramatic neuron loss and 
perinatal lethality (Labarca et al., 2001). Likewise, transgenic expression of ACR-
2(L/S) leads to cell-autonomous neurodegeneration. 
Importantly, our transgenic approach also enabled us to identify genes 
required for ACR-2(L/S) toxicity. Mutations that suppressed both the paralysis 
and neurodegeneration caused by ACR-2(L/S) expression defined the 
constituent subunits of a putative multimeric ACR-2 receptor complex as well as 
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genes required for receptor trafficking and assembly. Additionally, a single gene 
mutation in crt-1, previously shown to suppress other forms of ion channel-
mediated cell death in C. elegans, partially suppressed ACR-2(L/S) toxicity. We 
found that the loss of motor neurons caused by ACR-2(L/S) expression was 
completely suppressed in adult cnx-1;crt-1 double mutants; yet, these animals 
remained paralyzed. Interestingly, suppression of ACR-2(L/S)- induced cell death 
uncovered a secondary consequence of ACR- 2(L/S) expression: the 
accumulation of morphological defects in the processes of surviving motor 
neurons. These axonal defects resemble outgrowth errors typically associated 
with secondary regrowth of axons (Hammarlund et al., 2007; Knobel et al., 2001). 
Therefore, the severe morphological defects we observed in adult animals may 
reflect inappropriate regrowth subsequent to destabilization. We propose that the 
necrotic-like cell death and destabilization of neuronal processes observed in our 
studies may represent genetically separable events and suggest that our 
transgenic approach may afford a powerful system to tease apart the molecular 
pathways that differentially contribute to these two processes.  
ACR-2 is part of a heteromeric nAChR in cholinergic motor neurons  
We have demonstrated that acr-2 shows restricted expression to 
cholinergic motor neurons of the ventral nerve cord and appears diffusely 
localized in neuronal processes. These results suggest that the ACR-2 receptor 
complex may modulate motor neuron excitability by mediating signaling at 
extrasynaptic sites. Consistent with this notion, acr-2 loss-of-function mutants are 
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not grossly uncoordinated and show only modest resistance to the paralyzing 
effects of the ACh esterase inhibitor aldicarb. Aldicarb-induced paralysis arises 
as a consequence of the prolonged action of ACh in the synaptic cleft; our 
analysis suggests that ACh release from motor neurons is decreased in acr-2 
mutants. Another recent study reached a similar conclusion based on 
electrophysiological analysis of acr-2 loss-of-function mutants (Jospin et al., 
2009). We also show that the locomotory control interneurons (with the possible 
exception of AVE)—the major source of synaptic inputs to excitatory motor 
neurons—do not express a reporter that labels cholinergic neurons, suggesting 
these neurons are unlikely to be cholinergic. Therefore, what is the source of 
ACh for activation of ACR-2 receptor complexes? The presynaptic ACh release 
sites of en passant neuromuscular synapses are highly intermingled and densely 
packed because of the intercalation of neuronal processes in the nerve cord. 
Thus, one possibility is that these receptors are activated by spillover of ACh 
from release sites at nearby neuromuscular synapses.  
Our genetic analysis showed that mutations in three genes encoding 
AChR subunits can suppress the neurotoxic effects associated with expression 
of pore-modified ACR-2(L/S) receptors. unc-38 and unc-63 are highly expressed 
in ventral cord motor neurons and also contribute to a heteromeric receptor 
complex that mediates excitatory neurotransmission at the NMJ (Culetto et al., 
2004; Fleming et al., 1997). acr-12 is broadly expressed in the nervous system 
but is not expressed in body wall muscles (Cinar et al., 2005; Gottschalk et al., 
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2005). Our data are consistent with the notion that UNC-38, UNC-63, and ACR-
12 coassemble with the ACR-2 subunit [either native ACR-2 or transgenic ACR-
2(L/S)] to form heteromeric nAChRs in cholinergic motor neurons (Jospin et al., 
2009). Loss-of-function mutations in any of these genes impair assembly or 
function of ACR-2 receptor complexes in cholinergic motor neurons and 
suppress ACR-2(L/S)-induced cell death. Several pieces of evidence support this 
idea. First, mutations in unc-29 and acr-16—genes that contribute to nAChRs at 
the NMJ and are essential for normal excitatory neurotransmission at 
neuromuscular synapses (Francis et al., 2005; Richmond and Jorgensen, 1999; 
Touroutine et al., 2005)—do not suppress ACR-2(L/S) neurotoxicity, indicating 
that reduced excitatory neuromuscular signaling alone is insufficient to suppress 
ACR-2(L/S)-induced toxicity. Second, specific expression of acr-12 in the 
cholinergic motor neurons of transgenic acr-12 mutants expressing ACR-2(L/S) 
was sufficient to produce paralysis, whereas specific expression of acr-12 in 
other neuron classes was without effect. Third, it has recently been shown that 
coexpression of five subunits—ACR-2, ACR-12, UNC-38, UNC-63, and ACR-3— 
was required for reconstitution of ACR-2 receptor complexes in a heterologous 
system (Jospin et al., 2009).  
Pore-modified ACR-2(L/S) receptors cause ion channel-mediated 
neurotoxicity  
We have shown that expression of the ACR-2(L/S) transgene leads to 
degeneration of the cholinergic motor neurons and paralysis, reinforcing the 
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importance of these neurons in generating sinusoidal movement. The GABA 
motor neurons develop normally even in the absence of ACh motor neurons, 
their major source of synaptic input, indicating that the toxic effects of ACR- 
2(L/S) expression are cell autonomous. We found that mutations in genes that 
are essential for the formation of functional ACR-2 heteromeric receptors 
suppress this effect, consistent with the idea that excessive receptor activity 
leads to neurodegeneration. Our results suggest that the level of receptor activity 
is a critical determinant in the progression toward necrotic cell death. Consistent 
with this idea, a less severe gain-of-function acr-2 allele leads to cellular 
hyperexcitability without obvious loss of motor neurons (Jospin et al., 2009). 
Interestingly, mouse studies using knock-in expression of similarly pore-modified 
heteromeric nAChR subunits have reported qualitatively similar degeneration as 
a consequence of excess receptor activation (Labarca et al., 2001; Orb et al., 
2004; Orr-Urtreger et al., 2000). Knock-out of Lynx1, an endogenous negative 
regulator of nAChR function in the mouse brain, also leads to a similar form of 
vacuolating degeneration that is exacerbated by nicotine (Miwa et al., 2006).  
Release of calcium from internal stores plays a major a role in many forms 
of cell death, including some forms of ion channel mediated toxicity. 
Pharmacological or genetic manipulation of intracellular calcium levels led to a 
modest suppression of ACR- 2(L/S)-induced toxicity, providing evidence that 
calcium plays an important role. However, ACR-2::GFP fluorescence was 
decreased substantially in cnx-1;crt-1 double mutants, suggesting that a 
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reduction in protein levels of the toxic transgene also contributes to suppression 
of cell death. Similar to the case for ACR- 2(L/S) expression, cell death because 
of a gain-of-function mutation in another C. elegans nAChR subunit, DEG-3, is 
not suppressed by a single gene mutation in crt-1 (Syntichaki et al., 2002; Treinin 
and Chalfie, 1995; Xu et al., 2001). Our findings suggest that a requirement for 
genes additional to crt-1 may be a common feature of nAChR-mediated neuronal 
death that is distinct from cell death caused by hyperactive Na+ channels such as 
MEC-4(d).  
In mouse models of motor neuron disease, such as progressive motor 
neuronopathy (PMN) or the transgenic SOD1 G93A model of amyotrophic lateral 
sclerosis, apoptosis of neuronal cell bodies was blocked by expression of the 
anti-apoptotic Bcl-2 gene or knock-out of the proapoptotic Bax gene (Gould et al., 
2006; Sagot et al., 1995). In each case, degeneration of the neuronal processes 
continued unimpeded and disease progression was unaffected. ACR-2(L/S)-
induced cell death clearly occurs independently of the apoptotic pathway. 
However, it is interesting to note that we also observe a progressive 
destabilization of the motor neuron processes that leads to paralysis even under 
conditions when death of the cell body is attenuated. Therefore, NMJ denervation 
that occurs independently of the death of neuronal cell bodies is the dominant 
feature shared across each of these cases. In the future, it will be interesting to 
uncover the molecular events leading to degeneration of the neuronal processes 
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and determine whether elements of the degenerative process are conserved 











Figure A1-1. acr-2 is expressed in cholinergic motor neurons and 
modulates motor neuron activity. A, Confocal image of the posterior ventral nerve 
cord of an adult animal coexpressing a GABA-specific marker (Punc-
47::mCherry) and an ACR-2- specific marker (Pacr-2::GFP). No overlap is 
observed between GFP-expressing and mCherry-expressing neurons. The 
animal is oriented with the posterior (tail) on the right. B, Quantification of 
movement on a food-free agar plate. Average number of body bends per minute 
for wild type, acr-2(ok1887) mutants, and acr-2(ok1887) mutants expressing full 
length ACR-2::GFP (ufIs42) over a 5 min period are shown. Data represents 
mean ±SEM of at least 10 trials; **p<0.01 compared to wild type. C, Time course 
of paralysis in the presence of the cholinesterase inhibitor aldicarb (1 mM) for 
wild type, acr-2(ok1887) mutants, and acr-2(ok1887) mutants expressing full-
length ACR-2::GFP (ufIs42). The percentage of immobilized animals calculated 
every 15 min over a time course of 2 h is shown. Each data point represents the 













Figure A1-2. Transgenic animals expressing the dominant ACR-2(L/S) 
transgene are severely uncoordinated. A, B, Still image of a wild-type animal (A) 
and a transgenic animal expressing the ACR-2(L/S) transgene (B). Note the 
coiled posture and reduced size that occurs as a result of ACR-2(L/S) 
expression. C, Quantification of movement on a food-free agar plate. Average 
number of body bends per minute for wild type, acr-2(ok1887) mutants, and 
transgenic animals expressing full-length ACR-2(L/S) (ufIs25) counted over a 5 














Figure A1-3. Transgenic expression of ACR-2(L/S) leads to a loss of 
cholinergic motor neurons. A, A1, DIC images of an adult wild type animal (A) 
and an adult transgenic animal expressing ACR-2(L/S) (A1). Triangles denote 
lesions observed along the ventral nerve cord of transgenic animals expressing 
ACR-2(L/S). Images show a region directly posterior of the vulva and are 
oriented with the ventral surface facing up and the anterior of the animal to the 
left. B, B1, Wide-field epifluorescent images of a transgenic animal expressing 
the cholinergic neuron marker Punc-17::GFP (vsIs48) (B) and a transgenic 
animal coexpressing ACR-2(L/S) with Punc-17::GFP (B1). The few Punc-
17::GFP-labeled motor neurons that remain in transgenic ACR-2(L/S) animals 
include the six VCs (indicated) and a more variable group of ~10 –12 neurons 
(arrowheads). C, C1, Wide-field epifluorescent images of a transgenic animal 
expressing Punc-47::mCherry (C) and a transgenic animal coexpressing Punc-
47::mCherry with ACR-2(L/S) (C1). The full complement of Punc-47::mCherry-
labeled motor neurons remains in transgenic ACR-2(L/S) animals and is 
indicated. D, Quantification of the total number of motor neurons in wild-type 
(gray) and ACR-2(L/S) animals (black); *p<0.01. For all images, animals are 











Figure A1-4. ACR-2(L/S)-induced motor neuron cell death is initiated 
before hatch. A, B, Wide-field epifluorescent images of wild-type (A) and 
transgenic ACR-2(L/S) (B) animals expressing Punc-17::GFP imaged 16, 28, 38, 
and 48 h after bleach synchronization of embryos. C, D, Confocal images of first 
larval stage wild-type (C) and transgenic ACR-2(L/S) (D) animals expressing 
Punc-17::GFP. Swollen or dying neuronal cell bodies are indicated (arrowheads). 
E, Quantification of the average number of cell bodies at the time points indicated 
for wild type (black bars) and transgenic ACR-2(L/S) animals (gray bars). Bars 



















Figure A1-5. Mutations in nicotinic acetylcholine receptor subunits suppress 
ACR-2(L/S)-induced paralysis. A, Quantification of the average number of body 
bends per minute for wildtype animals, acr-12(ok367), unc-63(ok1075), unc-
38(e264), unc-74(e883), and unc-50(e306) mutants in the absence (gray bars) or 
presence (black bars) of the ACR-2(L/S) transgene. Animals were placed on a 
food-free agar plate, and the average number of body bends per minute was 
quantified over a 5 min period. Data represent the mean ±SEM of at least 10 
animals for each genotype. B, Schematic of the membrane topology of ACR-12 
with approximate location, allele names, and molecular nature of loss-of-function 
mutations that suppress ACR-2(L/S) toxicity indicated. C, Quantification of the 
average number of body bends per minute for the following genotypes: wild type, 
acr-12(ok367), transgenic ACR-2(L/S), acr-12 mutants expressing ACR-2(L/S), 
acr-12 mutants expressing ACR-2(L/S) together with an extrachromosomal array 
containing Punc-47::ACR-12, and acr-12 mutants expressing ACR-2(L/S) 
together with an extrachromosomal array containing the Pacr-2::ACR-12 cDNA. 
Data represent the mean ±SEM for 5–10 animals. D–H, Still images of adult 
animals on NGM plates without food for the genotypes indicated. “GABA” and 
“ACh” refer to specific expression of the acr-12 cDNA in GABAergic or 












Figure A1-6. ACR-2(L/S)-mediated motor neuron loss is completely prevented in 
animals doubly mutant for calnexin and calreticulin. A–F, Representative wide-
field images of Punc-17::GFP fluorescence in the ventral nerve cord of adult 
animals for the genotypes indicated. For each image the head is oriented to the 
left. The alleles used were ced-3(ok2734), cnx-1(ok2234), and crt-1(ok948). G, 
Quantification of the average number of Punc-17::GFP-labeled cell bodies 
present in the ventral nerve cord for the genotypes indicated. Data represent the 
mean ±SEM for at least 10 animals per genotype. * p<0.01, **p<0.01, compared 















Figure A1-7. Progressive destabilization of motor neuron processes in cnx-1;crt-
1;ACR-2(L/S) animals. A, B, Frames showing the movement of L1 transgenic 
ACR-2(L/S) (A) or cnx-1;crt-1;ACR-2(L/S) (B) animals 30 s (t 0), 60 s (+30), or 90 
s (+60) after transfer to an agar plate. The black arrow marks the starting 
positions of the worms in each frame. The transgenic ACR-2(L/S) animal does 
not move from where it was placed on the plate. The dashed line shows the 
movement path of the L1 cnx-1;crt-1; ACR-2(L/S) animal over the course of 60 s. 
The additional tracks on the plate show the path of the animal in an ~30 s period 
before imaging began. C, D, Confocal images of a first larval stage (C) or adult 
cnx-1;crt-1;ACR-2(L/S) animals expressing an integrated Punc-17::GFP (D). 
Images show Z-projections of 15 confocal planes (0.5μm/slice) (C) or 16 confocal 
planes (0.5μm/slice) (D). Arrows (D) indicate positions of commissures. Dashed 
box (D) indicates area with multiple neuronal defects. E–G, Confocal images of 
cnx-1;crt-1;ACR-2(L/S) animals taken at hatch (E), 24 h post hatch (F), and 
adulthood (G). In each case, a region immediately posterior of the vulva was 
imaged and the ventral nerve cord is positioned at the top. Arrows indicate 
commissural processes; arrowheads indicate the ventral nerve cord. Images 
show Z-projections of 12 confocal planes (E), 23 confocal planes (F), or 33 
confocal planes (G) (0.5μm/slice). Scale bars represent 10_m. H, Quantification 
of percentage of animals moving at hatch in ACR-2(L/S) and cnx-1;crt-1;ACR-
2(L/S) animals. Data represent the mean number of animals ± SEM making more 
than two consecutive body bends during a 3 min period. I, Quantification of the 
percentage of cnx-1;crt-1 and cnx-1;crt-1;ACR-2(L/S) animals with defective 
neuronal process morphology. Observed defects include defasciculation of the 














Figure A1-8. Perturbation of intracellular calcium and reduced ACR-2::GFP 
levels in cnx-1;crt-1 double mutants suggest dual mechanisms for cell death 
suppression. A–C, Quantification of the average number of Punc-17::GFP-
labeled cell bodies present in the ventral nerve cord in adult animals treated with 
dantrolene (A), L1 animals treated with EGTA (B), and adult unc-68(e540) 
mutant animals (C). Data represent the mean ±SEM for at least eight animals. 
**p<0.01, ***p<0.01, compared to untreated ACR-2(L/S) animals. D, E, Confocal 
images of adult wild type (D) or cnx-1;crt-1 (E) animals expressing ACR-2::GFP. 
Images are taken immediately posterior to the vulva and show Z-projections of 
seven confocal planes (0.5μm/slice). F, G, Quantification of fluorescence levels 
in cell bodies (F ) and ventral nerve cord processes (G) of wild-type and ACR-
2(L/S) animals transgenically expressing ACR-2::GFP. Data represent the mean 













Figure A1-S1. Expression of the non-alpha nAChR subunit ACR-2. (A) 
Schematic depicting morphology of cholinergic DA and DB motor neurons in an 
L1 animal. Wide-field epifluorescent projection images of the ventral (green) and 
dorsal (blue) nerve cords in L1 animals expressing integrated arrays containing 
either the transcriptional reporter Pacr-2::GFP (ufIs49, top), full-length Pacr-
2::ACR-2::GFP (ufIs42, middle) or a presynaptic marker (Punc-4::SNB-1::GFP, 
lower). Pacr-2::GFP fluorescence is present in both ventral and dorsal nerve 
cords. Expression of the synaptic vesicle marker synaptobrevin (SNB-1::GFP) is 
limited to axons of the dorsal nerve cord. ACR-2::GFP fluorescence is limited to 
dendrites in the ventral nerve cord. (B) Projection of a confocal stack showing the 
dorsal and ventral nerve cords of an adult animal expressing full-length ACR-
2::GFP. (C) Confocal image of ventral nerve cord showing diffuse ACR-2::GFP 
















Figure A1-S2. C. elegans command interneurons do not express Punc-17::GFP. 
(A-C) Single confocal images of an animal co-expressing an integrated array 
(vsIs48) containing the cholinergic neuron marker Punc-17::GFP together with an 
extrachromosomal array (ufEx158) containing Pnmr-1::mCherry. (D) A confocal 
projection showing the relative positions of neuronal cell bodies expressing Punc- 
17::GFP and Pnmr-1::mCherry in the head of the worm. Neurons expressing 
mCherry are indicated. Only a single AVA neuron expresses mCherry due to 














Figure A1-S3. Sequence features of ACR-2. (A) Amino acid sequence of ACR-2. 
Predicted signal sequence (dashed box), transmembrane domains (underline), 
cys-loop (gray), gain-of-function mutation (box), and site of GFP insertion 
(asterisks) are indicated. (B) Alignment of the second transmembrane domain of 
ACR-2 and various mammalian non-alpha subunits. The site of the 9’ leucine to 













Figure A1-S4. Wild type and ACR-2(L/S) animals have the same number of acr-
2 expressing cells at the 3-fold embryo stage. (A and B) Confocal images of wild 
type (A) and ACR-2(L/S) (B) 3-fold embryos expressing an integrated array 
containing Pacr-2::GFP (ufIs49). Images represent Z-projections of 23 slices (0.5 
μm/slice). (C) Quantification of the average number of Pacr-2::GFP labeled cell 
bodies present in wild type and ACR-2(L/S) 3-fold embryos. Data represents the 














Figure A1- S5. The VC neurons remain present in transgenic ACR-2(L/S) 
animals. Confocal images of wild type (A) and ACR-2(L/S) (B) animals 















Figure A1-S6. Motor neuron processes are irregular in cnx-1;crt-1 double 
mutants expressing transgenic ACR-2(L/S). (A and B) Confocal images of 
commissural processes and ventral nerve cord processes in cnx-1;crt-1 double 
mutants (A) and cnx-1;crt-1 double mutants expressing the ACR- 2(L/S) 
transgene (B). Arrowheads show normally fasciculated ventral nerve cord in cnx- 
1;crt-1 double mutants (A) and defasciculation in cnx-1;crt-1;ACR-2(L/S) animals 
(B). Arrows show normal commissural process in (A) and ectopic sprouting in 
(B). In each case, a region immediately posterior of the vulva was imaged and 
the ventral nerve cord is positioned at the bottom. Images show Z-projections of 
34 confocal planes (A) or 33 confocal planes (B) (0.5 μm/slice). For all 
fluorescent imaging, animals are expressing an integrated Punc-17::GFP 
transgene (vsIs48). (C) Quantification of the percentage of irregular commissural 
processes in wild type (15 commissures from 5 animals), transgenic ACR-2(L/S) 
(39 commissures from 10 animals), cnx-1;crt-1 (75 commissures from 19 
animals) and cnx-1;crt-1;ACR-2(L/S) (93 commissures from 17 animals). Since 
Punc-17::GFP also labels AS motor neurons that project commissural axons and 
do not express acr-2, the percentage of axonal defects in ACR-2(L/S) expressing 













Table A1-S1. Suppressors of ACR-2(L/S) induced paralysis isolated from a 
forward genetic screen.  
Gray shading denotes available alleles used as reference  
*denotes percentage of animals paralyzed after 120 minutes in the presence of 
200 μM levamisole  
†Alleles listed multiple times indicated duplicate isolates of the same allele. 
Forty-four additional levamisole-resistant mutants (<20% paralyzed) were 
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